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Glossary of terms 
ANOVA = analysis of variance  
ATS = American Thoracic Society  
AX 
 
= the area between the reactance curve and 
the x axis 
 
BALF = bronchoalveolar lavage fluid  
BALT =bronchus-associated lymphoid tissue  
BHR = bronchial hyperresponsiveness  
cGMP = cyclic guanosine monophosphate  
CO2 = carbon dioxide  
dUTP = deoxyuridinetriphosphate  
ED 100 
 
= the methacholine dose causing a 100% 




= the methacholine dose causing a 50% 
increase in the airway resistance 
 
EELV = end-expiratory lung volume  
ERS = European Respiratory Society  
FEF25-75 
 
= forced expired flow between 25% and 




= forced expiratory volume in the first 
second of expiration 
 
FOT = forced oscillation technique  
Fr = resonant frequency  
FVC = functional vital capacity  
G = tissiou damping  
GINA = Global Initiative for Asthma  
H = elastance  
η = lung tissue hysteresivity  
His = histamine  
Iaw = airway inertance  
ID = internal diameter  
 
 
j = imaginary unit 
LFOT = forced oscillations at low frequenties 
MCh = methacholine 
MLI =mean linear intercept 
NO = nitric oxide 
O2 = oxygen 
Pbox = box pressure 
PBS = phosphate-buffered saline 
PDE = phosphodiesterase 
PMN = polymorphonuclear cells 
Ptr = tracheal pressure 
R4-24 
 
= average resistance between 4 and 24 Hz 
R6 = resistance at 6 Hz 
Raw = airway resistance 
ROS = reactive oxygen species 
RSD = red sludge dust 
Sal = salbutamol 
SD = standard deviation 







= terminal deoxynucleotidyl transferase-
mediated deoxyuridinetriphosphate nick 
end-labeling 
VEGF = vascular endothelial growth factor 
VIP = vasoactive intestinal peptide 
Zrs 
 







Asthma, the most frequent chronic lung disease in childhood, is a considerable health problem 
worldwide. Asthma is a heterogeneous condition with numerous different phenotypes, which 
can be explained by complex environmental/genetic interactions. Since breathing is a process 
involving adaptation to environmental changes, various detrimental changes in the lung 
function or structure may be related to alterations in the ambient conditions. Besides 
biophysical and economic/psychosocial causes, environmental factors can also pose a high 
risk of the development of asthma or asthma-like symptoms. Exposure to indoor/outdoor 
allergens, tobacco smoke or air pollution and an urban lifestyle may also play a part in the 
emergence of the disorder. Such stimuli can provoke an immune response leading to an 
imbalance in the production of anti-inflammatory/inflammatory cytokines. The chronic 
presence of inflammation results in a hypersensitive reaction in the airways, which is a 
characteristic feature of asthma. This bronchial hyperresponsiveness (BHR) is manifested in 
exaggerated responses to a wide range of seemingly harmless stimuli involving a constriction 
of the airway smooth muscle, an elevated secretion of the submucosal glands and swelling of 
the bronchial wall.The mechanisms underlying BHR are not completely understood, since it 
can be related to both asthmatic and non-asthmatic, non-atopic disorders. In adults, a strong 
relationship has been demonstrated between airway remodeling and BHR, whereas the 
development of these severe structural changes in children is exceptionally rare, which may 
be anticipated from the normal basal lung functional parameters in the periods between the 
exacerbations. In the early stages of the disease therefore, genetic factors and existing 
inflammation are most probably responsible for the development of BHR. In humans, the 
effects of environmental and genetic factors in the pathogenesis of asthma cannot be 
distinguished. Inbred animals, however, may serve as ideal models via which to investigate 
the roles of environmental factors and inflammation without the confounding influence of the 
genetic background.     
1.1 Dust inhalation and BHR 
Previous studies have indicated that the inhalation of various dust particles may involve long-
term adverse pulmonary effects that may promote the development of chronic obstructive 
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pulmonary disease (27), sarcoid-like pulmonary disease (36) and diffuse parenchymal lung 
disease (86); furthermore, airway irritation following the inhalation of ambient particulate 
matter contributes to an increased prevalence and the exacerbation of asthma (17, 42, 45, 63, 
92). The unfortunate red sludge disaster that occurred when the pond dam of a red sludge 
reservoir plant burst on October 4 2010 gave rise to an extreme situation and health hazard in 
the area near the Hungarian town of Ajka. The 600,000-700,000 m
3
 of toxic red sludge that 
streamed out from the damaged reservoir flooded 3 towns and affected 4 other residential 
areas, in some places in a depth of up to 2 meters, and rapidly covered an agricultural area of 
about 40 km
2
. Health professionals agreed that the most important health risk was related to 
the inhalation of the red sludge dust (RSD) formed when the red sludge dried and its particles 
were swept into the atmosphere by the wind. Since the atmosphare may also be contaminated 
the RSD if the common dry storage method is used for the deposition of this byproduct, this 
environmental threat may additionally involve workers or inhabitants in regions neighboring 
plants where alumina is produced from bauxite by the Bayer process.  
1.2 Hyperoxia-induced lung damage 
The initial mechanisms of inflammation and the subsequent BHR are related to the increased 
production of reactive oxygen species (ROS). In developing, immature lungs, the fact that the 
antioxidant system is underrepresented also contributes to the imbalance in the 
oxidant/antioxidant regulation. ROS molecules can be produced excessively by oxygen (O2) 
toxicity cause both direct and indirect damages at molecular and cellular levels leading to 
apoptosis and the activation of an inflammatory response.  
O2 therapy involving prolonged exposure to an elevated concentration of O2 is routinely 
applied in clinical practice to enhance oxygenation in the presence of compromised gas 
exchange. While the adverse pulmonary consequences of O2 toxicity have been well 
established, hyperoxia exposure is often required in clinical situations involving severerly 
compromised oxygenation, such as in premature neonates (9, 38-40) or in patients with acute 
lung injuries (93). Since prolonged exposure to an elevated O2 concentration poses the risk of 
long-term adverse alterations in the lung architecture and pulmonary function (78), the 
prevention of hyperoxia-induced lung injury is of major importance. Although the molecular, 
structural and functional changes in the lungs are manifested simultaneously in the early 
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phase of hyperoxia-induced lung damage, these concomitant alterations are poorly 
characterized. Moreover, previous studies assessed the functional changes only in long-lasting 
animal models in which the airway and vascular remodeling had already taken place (14, 34, 
35, 82, 87). It is therefore of fundamental importance to develop an animal model with which 
the short-term effects of hyperoxia on inflammation and BHR can be systematically 
characterized. With such a model, the effectiveness of preventive strategies against O2 toxicity 
can also be investigated. Many previous studies have highlighted the roles of epithelial and 
endothelial cell injuries following hyperoxia and the consequent decrease in nitric oxide (NO) 
production in the lungs, which may lead to an imbalance in the relaxation/constrictive 
regulation of the smooth muscle (54, 61, 83). NO activates the enzyme guanylate cyclase, 
which facilitates stimulation of the enzyme protein kinase G by cyclic guanosine 
monophosphate (cGMP), leading to a decrease in the intracellular Ca
2+
 level and then to 
relaxation of the smooth muscle (41). Besides this major regulatory role, NO also affects the 
lung structural development, including alveolarization (6), and is involved as a mediator of 
the non-adrenergic, non-cholinergic nervous system in the pathogenesis of the inflammatory 
response and in the regulation of the pulmonary circulation (25). These functions are 
inactivated in a hyperoxic environment (11), which compromises the effect of NO and NO- 
dependent pathways by increasing the activity of cGMP-dependent phosphodiesterases 
(PDEs), resulting in impaired airway relaxation (44) and abnormal angiogenesis (20, 44). 
Thus, restoration of the NO-dependent processes with a PDE5 inhibitor, such as sildenafil, 
may provide an effective protection against the development of lung injury following 
hyperoxia (44). The lack of the NO-mediated effects may also be compensated by enhancing 
the vasoactive intestinal peptide (VIP) pathway, which additionally regulates the smooth 
muscle tone, and potentiates the release of NO from the endothelium and the VIP/NO-
containing nerve fibers (1, 3, 52). All these mechanisms indicate that influencing these 
pathways may be beneficial in the protection against hyperoxia-induced lung injury. 
1.3 Detection of BHR  
The assessment of BHR plays a key role in the diagnosis of asthma (12, 15, 29, 43). Since 
asthma frequently begins during childhood, the early diagnosis and adequate treatment of 
asthma in an early state significantly improve the prognosis and the quality of life (79). In 
older children or adults, the BHR can be detected indirectly by performing spirometry during 
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airway challenges with an inhaled bronchoconstrictor agonist. Carefully dosed and monitored 
bronchoconstrictors such as methacholine (MCh), histamine (His), adenosine, cold air or 
exercise provoke the symptoms resulting in the airway obstruction which reflects the 
worsening of the lung function and the appearance of clinical signs. The confirmatory test for 
the lung function in asthma is based on forced expiratory maneuvers beginning at school age. 
The airway obstruction leads to a reduced airflow during forced exhalation (e.g. the average 
forced expired flow between 25% and 75% of the volume expired- FEF25-75) and smaller 
partial expiratory lung volumes (e.g. the forced expiratory volume in the first second of 
expiration- FEV1). The forced vital capacity (FVC) may be normal because of the 
hyperinflated lungs in asthma and a diminished ratio FEV1/FVC is therefore also an 
informative sign of the obstruction. Although forced expiratory maneuvers furnish valuable 
parameters to through which detect BHR, such measurement of the lung function in young 
(preschool) children is limited by their inability to provide the close cooperation necessary for 
spirometry.  
The forced oscillation technique (FOT) has gained increasing attention for the measurement 
of respiratory mechanics in children because this approach requires no special breathing 
maneuvers (22, 69). Furthermore, the FOT measures the input impedance of the respiratory 
system (Zrs) with, its real part directly reflecting the overall airway caliber and the imaginary 
part related to the elasticity of the respiratory tissues. Thus, in contrast with spirometry, the 
FOT provides direct information on the mechanical properties of the airways and the 
respiratory tissues. These beneficial properties of the FOT have resulted in numerous previous 
studies in which the lung function was assessed in children with no respiratory disease (30, 
64, 88), or with various lung diseases such as cystic fibrosis (23, 24, 49, 77, 88), neonatal 
chronic lung disease (88, 90), wheezy bronchitis (68, 88, 94, 95) or asthma (12, 29, 43, 64, 
88). Despite the potential of the FOT to detect early bronchoconstriction following different 
challenges, the sensitivity of this method for the detection of BHR has not been systematically 
compared with that of the gold standard spirometry in asthmatic children. The efficiency of 
FOT in the detection of BHR has already been confirmed in animal studies and this technique 
has been shown to be an appropriate method for the assessment of changes in airway and 
respiratory tissue mechanics.  
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2 AIMS OF THE STUDIES INCLUDED IN THE PRESENT THESIS 
The main goals of the studies included in the present thesis are related to the attainment of a 
greater understanding of the underlying mechanisms of BHR. Specifically, the studies were 
designed with three particular aims: 
 
 To investigate the consequences of chronic RSD inhalation on the airway and 
respiratory tissue mechanics in an animal model. We further set out to explore whether 
chronic RSD exposure leads to BHR, which is the hallmark feature of airway 
susceptibility. 
  
 To unravel the links between the morphological, biochemical and functional changes 
in the early phase of hyperoxia exposure and to assess the effectiveness of preventive 
treatment by enhancing the NO/cGMP pathway in an animal model of short-term O2 
exposure in immature rats. We hypothesized that sildenafil and VIP have the potential 
to exert protection in the early phase of hyperoxia-induced lung damage and BHR by 
inhibiting the initiation of the cascade mechanism that leads to an irreversible lung 
injury in developing lungs. 
 
  
 To establish which FOT parameter is most appropriate for the detection of BHR in 
asthmatic children, and more specifically to compare the sensitivities of the FOT and 
spirometry during airway challenges involving the inhalation of various direct stimuli 
commonly utilized in clinical practice (His and MCh). 
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3 MATERIALS AND METHODS  
The RSD exposure protocol was approved by the Experimental Ethics Committee of the 
University of Szeged (I-74-17/2010) and the Animal Health and Welfare Office of the local 
authorities in Hungary. The experimental protocols on Sprague-Dawley rats were approved 
by the Experimental Ethics Committee of the University of Geneva and the Animal Welfare 
Committee of the Canton of Geneva (1051/3691/II).  
The clinical research protocol was approved by the Clinical Ethics Committee of the 
University of Szeged (Ref. No. WHO2803). 
3.1 Animal research studies 
3.1.1 RSD inhalation  
Certified red sludge samples were obtained from the local office of the National Directorate 
General for Disaster Management in Devecser 10 days after the disaster. The red sludge was 
dried in an oven at 60 C for 24 h and the resulting dry material was mechanically ground to 
form a powder containing fine particles able to furnish a cloud of RSD in an air flow. The 
particle size distribution was determined. The resulting RSD was then placed in a sealed glass 
container with two tubes passing through its lid. The internal end of one of these tubes was 
immersed in the RSD and the other end was attached to the inspiratory port of a small animal 
ventilator (model 683, Harvard Apparatus Co. Inc., South Natick, MA, USA). The internal 
end of the other tube was kept above the RSD, while the other end was connected to the inlet 
of the exposure chamber. This system cyclically raises a cloud of dust in the RSD container 
during the inspiratory phases of the ventilator. The airborne flow of RSD by wind was 
Figure 1. Experimental set-up for RSD exposure. 
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mimicked by shaking the glass container containing the RSD for 20-30 s every 60-90 min, 
which intensified the access of particles to the inspiratory port and subsequently increased the 
RSD concentration in the exposure chamber. Since the ventilator frequency was maintained at 
50 strokes/min with the stroke volume set at 30 ml during exposure, this apparatus ensured 
the supply of fresh ambient gas into the exposure chamber, which contained a maximum of 5 
animals at a time. The exposure chamber was connected to the atmosphere via a bacterial 
filter in order to avoid contamination of the room air with RSD particles (Fig. 1.)  
Two groups of male Wistar rats were studied (weight range 350-455 g). The animals in the 
RSD group were exposed to RSD in the exposure chamber for a continuous period of 8 h a 
day for 2 weeks (n=10). The animals in the control group underwent the same procedure 
except that they were allowed to breathe room air (n=11). The rats in both groups had access 
to food and water ad libitum throughout the entire exposure period. The experiment was 
performed on day 15 (Fig. 2.). 
 
3.1.2 Hyperoxia exposure 
Weanling male Sprague-Dawley rats (80-125 g) were exposed to either hyperoxia (>95% O2) 
or normoxia (room air, Group C, n=8) for 72 h. The hyperoxia-exposed animals were 
randomized to 3 groups: no additional treatment (Group HC, n=8), the oral administration of 
sildenafil (20 mg/day; Pfizer, Zürich, Switzerland Group; HS, n=7) or the ip injection of VIP 
(150 µg/day; Sigma-Aldrich, Buchs, Switzerland, Group; HV, n=8), in both cases starting 
simultaneously with the commencement of the exposure to hyperoxia.  
During the 72-h O2 or room air exposure, the rats were kept in a 98-l sealed normobaric 
Plexiglas chamber (Elega, Geneva, Switzerland). The chamber was opened for a short time 
(<5 min) to allow delivery of the daily treatments. The O2 and carbon dioxide (CO2) levels 
were checked twice a day (Datex, Helsinki, Finland). The CO2 level in the box was 
maintained below 1% by using a CO2 absorber (Sodasorb, Asid Bonz GmbH, Herrenberg, 
Germany). Food and water were available ad libitum. 
Figure 2. Experimental protocol after RSD or room air exposure on day 15. 
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The experiment was performed on day 4 (Fig. 3.). 
 
3.2 Clinical research study on asthmatic children 
Twenty asthmatic children (5 girls and 15 boys, age range 5-18 years) were enrolled into the 
study. Asthma was diagnosed according to the Global Initiative for Asthma (GINA) 
guidelines (8), based on the previous history of recurrent coughing, wheezing, shortness of 
breath (at rest or following exercise), and the symptomatic improvement following short-
acting bronchodilator administration. Each child and/or their guardian completed the 
informed consent document, which was approved by the Clinical Ethics Committee of the 
University of Szeged (Ref. No. WHO2803). Seventeen children did not receive any regular 
asthma medication during one month prior to the study; they used only inhaled salbutamol 
(Sal) occasionally as needed. Three children used inhaled corticosteroid as maintenance 
(budesonide 200 µg twice a day) and Sal (200 µg as needed) as rescue therapy. Only patients 
who did not need Sal during 8 h before the visit were included in the study. The children 
visited the pulmonary function laboratory twice in 2 weeks. On the first occasion His 
provocations were performed, and 2 weeks later the measurements were repeated with MCh 
challenges. 
Figure 3. Experimental protocol after hyperoxia or room air 
exposure on day 4. The animals were mechanically ventilated 
(model 683; Harvard Apparatus, South Natick, MA, USA) with a 
tidal volume of 8 ml/kg, a respiratory rate of 110 breaths/min and 
a positive end-expiratory pressure of 2.5 cmH2O. Anesthesia was 
maintained with the repeated administration of 50 mg of chloral 
hydrate every hour. After completion of the end-expiratory lung 
volume (EELV) measurements, a femoral artery was cannulated 
and attached to a pressure transducer (model 156 PCE 06-GW2; 
Honeywell, Zürich, Switzerland) to allow monitoring of the 
systemic blood pressure. The femoral vein was also catheterized 
for drug delivery. This line was used for the MCh provocation 
(Bichsel AG, Interlaken, Switzerland). Intratracheal pressure, 
systemic blood pressure, ECG and rectal temperature were 
monitored throughout the experiments (Biopac, Santa Barbara, 
CA, USA). Body temperature was maintained at 37±0.5°C through 
use ofa homeothermic blanket system (Homeothermic monitor; 
Harvard Apparatus, Edenbridge, UK). 
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3.3 Lung function measurements 
3.3.1 Respiratory mechanics- FOT 
The frequency ranges studied in the various protocols were chosen in accordance with the 
research question and the measurement conditions. Thus, a low-frequency oscillation 
technique (LFOT) was applied in rats in order to assess the airway and respiratory tissue 
mechanics (elastance- H and damping- G) separately. Otherwise, the medium frequency range 
was studied in spontaneously breathing children since it provides detailed information 
concerning the mechanical status of the airways and the respiratory tissue elasticity without 
the need for an apneic period. 
3.3.1.1 Measurements in rats 
Zrs was estimated with the LFOT, as described in detail previously (73). Briefly, the tracheal 
cannula was connected to a loudspeaker-in-box system generating a composite signal 
containing 23 components at low 
frequencies (0.5-20.75 Hz). The 
forcing signal was driven through a 
100-cm-long and 2-mm-ID 
polyethylene wave-tube into the 
trachea during 6-s apneic periods. Two 
identical pressure transducers (Model 
33NA002D; ICSensors, Malpitas, CA, 
USA) were used to measure the lateral 
pressures at the loudspeaker and at the 
tracheal end of the wave-tube (Fig. 4.). A deep inspiration to a pressure of 30 cmH2O was 
applied before the first FOT measurement so as to standardize the volume history. The 
mechanical ventilation was then paused at end-expiration, and 4-6 6-s-long recordings were 
collected at 1-min intervals between each measurement under baseline conditions and 
following MCh provocations. Zrs was calculated by applying the transmission line theory 
(91). A model including frequency-independent resistance (Raw), inertance (Iaw) and a 
constant-phase tissue compartment with tissue parameters for G and elastance H was fitted to 
the ensemble-averaged Zrs spectra (31): 
Figure 4. Experimental set-up for FOT measurements. 
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Zrs = Raw + jωIaw + (G-jH)/ωα 
where j is the imaginary unit, ω is the angular frequency (2πf) and α=2/π arctan (H/G). The 
parameters Raw and Iaw can be attributed to the airways, while G and H represent the viscous 
(damping or resistive component) and elastic properties, respectively, of the respiratory 
tissues. The lung tissue hysteresivity () was calculated as =G/H (21). The model was fitted 
to each average impedance spectrum by minimizing the differences between the measured 
and the modeled impedance data. The optimization procedure was used with a relative 
(weighted) fitting criterion: the differences between the measured and modeled impedance 
values were normalized by the impedance magnitude at each frequency point (32). 
3.3.1.2 Measurements with the classical setup in human patients 
The FOT measurements were performed in accordance with the European Respiratory Society 
(ERS) guidelines (69). To measure Zrs during spontaneous breathing, a commercially 
available device (i2m, Chess Medica, Oostakker, Belgium) was applied. Briefly, a 
loudspeaker was used to generate the pseudorandom broad-band oscillatory pressure signals 
containing integer multiple frequencies between 4 and 48 Hz. The forcing signal was applied 
to the child via a disposable bacterial filter and a mouthpiece (Type PBF-30, Piston Ltd, 
Budapest, Hungary). Zrs was obtained from 8-s-long measurements while the child performed 
normal breathing during the oscillatory measurements. The equipment was calibrated by 
measuring known impedances prior to the measurements. The additional impedance of the 
bacterial filter and mouthpiece was determined and the Zrs spectra were corrected for this 
equipment component. 
During the 8-s-long data-recording periods, the children sat upright, wearing a noseclip and 
breathing quietly through the mouthpiece. They were asked to support their cheeks with their 
palms during these maneuvres in order to minimize upper airway shunting. The Zrs 
recordings were accepted if the coherence functions between the pressure and flow signals 
were generally greater than 0.95, no leak was noted around the mouthpiece, and no technical 
artefact occurred due to coughing, swallowing or glottis closure. 
The changes in the resistive properties of the respiratory system were evaluated by calculating 
the average resistance between 4 and 24 Hz (R4-24) and by extracting the resistance at 6 Hz 
(R6; the lowest frequency where the resistance was reliably measured). The elasticity of the 
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respiratory system was assessed by calculating the sum of all negative values in the imaginary 
part of Zrs from 4 Hz, which corresponds to the area between the reactance curve and the x 
axis (AX), and resonant frequency (Fr) was also extracted. 
3.3.2 Spirometry 
Spirometry is the gold standard lung function measurement in the clinical practice. Since the 
forced expiratory maneuvers need a high level of cooperation from the patient, this 
measurement technique can be used only in the clinical research field. In our study on 
asthmatic children, spirometry was performed in accordance with the American Thoracic 
Society (ATS)/ERS recommendations (59). Forced expiratory flow-volume curves were 
measured by means of a commercial spirometer (Type PDD-301/s, Piston Ltd, Budapest, 
Hungary), including a screen pneumotachograph equipped with a differential pressure 
transducer. The flow signal was integrated to obtain the changes in lung volume during the 
forced expiratory maneuvers. FEV1, FVC and FEF25-75 were extracted from the recordings. 
Three technically acceptable reproducible measurements were made, and the highest values of 
the spirometric parameters were extracted for the final analyses.  
3.3.3 Plethysmography in rats exposed to hyperoxia or room air  
End-expiratory lung volume (EELV) was measured at a positive end-expiratory pressure of 
2.5 cmH2O by using a whole-body plethysmograph (620 ml), as detailed previously (37). The 
rats were anesthetized with an ip injection of chloral hydrate (350 mg/kg) for the surgical 
preparation of the tracheotomy and the trachea cannulation. Briefly, the rats were placed in a 
supine position in a sealed Plexiglas chamber. The tracheal cannula was connected to the 
respirator and also to a pressurized (2.5 cmH2O) loudspeaker chamber. Before the 
measurement, the mechanical ventilation was paused, the plethysmograph was opened to the 
atmosphere and the trachea was opened to the loudspeaker chamber to equilibrate the lungs to 
a pressure of 2.5 cmH2O. The airway opening and the plethysmograph box were then closed 
until the first few breathing efforts generated by the animal against the closed trachea. Six-to-
eight breathing maneuvers were recorded for 10 s by measuring the tracheal (Ptr) and box 
(Pbox) pressure changes. The recordings of Pbox were then corrected for the thermal properties 
of the plethysmograph. Via Boyle’s law, EELV was calculated from the relationship between 
the corresponding changes in Ptr and Pbox (37).  
18 
 
3.4 Bronchoprovocation and reversibility tests  
3.4.1 Intravenous challenges 
3.4.1.1 Assessment of BHR with iv bolus of MCh  
An iv bolus of MCh at a dose of 2 µg/kg was administered into the tail vein, and Zrs was 
recorded 20 s, 1 min and 2 min after the injection. Previous experiments had revealed that the 
peak response occurs at 20 s after the MCh injection, and the effect is diminished 2 min later 
(65).  Following this transient constriction, the animal was allowed to recover, and further iv 
MCh challenges were given with elevation of the MCh dose to 4, 8 and 16 g/kg. The peak 
increases in the mechanical parameters were observed 20 s after the MCh injection; these 
increases were related to those obtained from the average of the three baseline Zrs recordings. 
The MCh dose causing a 100% increase in Raw (ED100) was calculated by linear interpolation 
of the dose-response curves from the individual animals. 
3.4.1.2 Stable bronchoconstriction with infused MCh 
To assess the lung responsiveness, MCh was infused iv in incremental doses from 4 to 8 and 
16 µg/kg/min. The development of stable bronchoconstriction (Raw values within 5%) 
required 5 min. Three Zrs data recordings were collected and ensemble-averaged under 
steady-state conditions 6 min after the onset of MCh provocation at each infusion level. After 
the last dose, a 15-min period was allowed for the rat to recover from the bronchoconstriction 
and 3 further Zrs recordings were made and ensemble-averaged. The equivalent dose causing 
a 50% increase in Raw (ED50) was calculated by linear interpolation. 
3.4.2 Aerosol challenges in children 
Increasing doses of aerosolized (Voyage Mefar jet nebulizer, Italy) His (Sigma-Aldrich Ltd, 
Budapest, Hungary) were administered to the children for 2 min via a face mask, in doubling 
doses ranging from 0.5 to 16 mg/ml. A set of Zrs recordings and three forced expiratory 
maneuvers for spirometry were collected after each dose. An interval of at least 5 min was 
allowed between two consecutive doses. The study was terminated before the highest dose of 
histamine, or if FEV1 decreased by more than 20% and/or clinical symptoms of wheeze or a 
persistent cough were noted (10, 16). To detect the reversibility of the bronchoconstriction, 
the challenge protocol was terminated in all children by administering 400 µg of inhaled Sal 
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(Ventolin; GlaxoSmithKline, Greenford, UK), followed by the final assessment of Zrs and 
spirometry. The children revisited the lung function laboratory 2 weeks later. The baseline 
FOT and spirometry were performed identically as detailed above. Aerosolized saline as the 
solvent of the agonists was then administered for 2 min, and both the FOT and spirometry 
were repeated. The bronchoprovocation tests with increasing doses of MCh (0.5 to 8 mg/ml 
for 2 min) and the broncholysis with Sal was then repeated in the same manner as detailed 
above. 
3.5 Lung inflammation, morphological and biochemical assessments in rats 
3.5.1 Lung histology following RSD inhalation 
Representative lung tissue sections (from the mid portion of both lungs) were embedded in 
paraffin blocks. Transhilar horizontal sections (perpendicular to the longitudinal axes of the 
lung from the hilum) were embedded in paraffin. Two 5-μm sections were prepared in each 
lung specimen and were stained with hematoxylin-eosin. All slides were examined by the 
same investigator in a blind fashion and in a random sequence. A lung injury score was used 
to quantify the changes in lung morphometry observed under a light microscope. The degree 
of microscopic injury was scored with regard to the following variables: blood congestion 
(hyperemia), infiltration of perivascular and perialveolar inflammatory cells (lymphocytes, 
plasma cells and macrophages), and the presence of bronchus-associated lymphoid tissue 
(BALT) or its hyperplasia. The severity of injury was graded as follows for each of the four 
variables: no injury (None), injury involving up to one-third of the field (Mild), injury 
involving up to two-thirds of the field (Moderate) and diffuse injury throughout the field 
(Severe). 
3.5.2 Bronchoalveolar lavage and lung histology in hyperoxic and normal rats 
Since inflammation plays an important role in the development of hyperoxia-induced lung 
injury, bronchoalveolar lavage fluid (BALF) was collected in order to analyze the 
inflammatory response to hyperoxia in the lungs. The lungs were instilled with 3 ml of 
phosphate-buffered saline (PBS, 37 °C) via the tracheal cannula at a pressure of 20 cmH2O. 
From the withdrawn BALF, the total cell number was counted in a Neubauer hemocytometer 
by using the trypan blue exclusion method. The BALF was then centrifuged at 200 x g for 10 
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min at 4 °C. The BALF supernatant was collected to assess the protein content (PIERCE BCA 
assay kit; Rockford, IL, USA). The cell pellet was resuspended at 10
6 
cells/ml in PBS 
containing 1% bovine serum albumin, and the level of alveolar cell repartition was 
determined on cytospin after May-Grünwald Giemsa staining. At the end of the experiment, 
the left lung was clamped to avoid the formalin fixation. The right lung was fixed with 4% 
formaldehyde under a pressure of 20 cmH2O and embedded in paraffin. The 6-m sections 
were stained with hematoxylin-eosin. Full-section images were captured with a MIRAX 
MIDI system (Carl Zeiss MicroImaging GmbH). Digitalized images were analyzed for 
perivascular edema by using Panoramic Viewer software (3DHISTECH, Budapest, Hungary) 
and for lung alveolar geometric structure and density by mean linear intercept (MLI) 
measurement, using Image J software (version 1.46r, NIH, Bethesda, USA) by the same 
investigator in a blind fashion and in a random sequence.   
3.5.3 Hyperoxia-induced apoptosis 
The left lung was clamped, removed and preserved in Optimal Cutting Temperature 
Compound at -80 °C. Terminal deoxynucleotidyl transferase (TdT)-mediated 
deoxyuridinetriphosphate (dUTP) nick end-labeling (TUNEL) was performed on lung 
cryosections according to the protocol for the In Situ Cell Death Detection Fluorescein Kit 
(Roche, Mannheim, Germany). Briefly, 6-µm lung slices were fixed with 4% formaldehyde 
for 10 min at room temperature and next permeabilized for 2 min with 0.1% Triton X-100 in 
0.1% sodium citrate at 4 °C. The slices were then incubated with the labeling mix containing 
TdT and fluorescein-labeled dUTP for 1 h at 37 °C. Fluorescent staining of total nuclei was 
performed with 250 ng/ml 4',6-diamidino-2-phenylindole (Sigma) for 5 min at room 
temperature. The slides were mounted with FluorSave Reagent (Calbiochem, Nottingham, 
UK). Images for analysis were acquired by confocal microscopy (LSM 510 Meta; Carl Zeiss 
MicroImaging GmbH, Jena, Germany) and cells were counted by using MetaFluor 
Fluorescence Ratio Imaging Software (version 7.7.6; Molecular Devices, Sunnyvale, USA). 
The ratio of the number of apoptotic nuclei as a percentage of the total number of nuclei was 
calculated.   
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3.6 Statistical analysis 
In the animal studies, the Shapiro-Wilk test was used to test data for normality. The 
mechanical parameters were normally distributed. Accordingly, two-way repeated measures 
analysis of variances (ANOVA), with variables of MCh dose (baseline, 4, 8, 16 µg/kg/min, or 
baseline, 2, 4, 8, 16 µg/kg) and groups (C, HC, HS and HV or RSD and Control Groups), was 
used to evaluate the effects of hyperoxia or RDS inhalation on the lung responsiveness to the 
bronchoconstrictor provocation. The MCh doses causing a 50 or 100% increase in Raw (ED50 
or ED100) were calculated by linear interpolation of the dose-response curves from the 
individual animals. 
To analyze the effects of hyperoxia on the inflammatory response (total cell number, 
percentage of polymorphonuclear cells-PMN and protein), or on the functional and structural 
changes (ED50, EELV, MLI and edema) and on the apoptosis, one-way ANOVA with the post 
hoc Holm-Šidák test was used in the event of normal distribution. When the distribution was 
not normal, ANOVA on ranks was applied for the statistical analysis.  
Since the histological data following RSD inhalation were not distributed normally, the 
Wilcoxon signed rank test was used to compare these findings between the protocol groups.  
In the human study, short-term variability in the spirometric and FOT parameters was defined 
as the standard deviation of percentage changes between measurements before and after saline 
inhalations, while long-term variability was determined by calculating the standard deviation 
of the percentage changes between the two baseline values at the two visits. The SD index for 
each parameter was calculated as the difference between the post-test and the basal value 
divided by the short-term SD. The Kolmogorov-Smirnov test was used to test data for 
normality. The changes in the FOT and spirometric parameters were assessed by using one-
way ANOVA tests on repeated measures. The relationships between the continuous variables 
(i.e. the FOT and spirometry indices) were examined by means of Pearson correlation tests. 
Pairwise comparisons were performed by using the Student-Newman-Keuls multiple 
comparison procedures.  
The values are reported as means±SE. Statistical significance was accepted at the level 
p<0.05. The statistical tests were performed with a SigmaPlot software package (version 11, 




4.1 Basal respiratory mechanical parameters in animal studies 
4.1.1 RSD vs. room air inhalation 
Figure 5. illustrates the baseline values of the airway and respiratory tissue mechanical 
parameters for the rats in both groups. RSD exposure did not lead to any significant change in 
Raw (p=0.65) or  (p=0.90). There was a tendency for G and H to increase in the rats exposed 





































































































Figure 5. Baseline (BL) values of airway resistance (Raw), respiratory tissue damping (G) and elastance (H), 
and hysteresivity (η) in individual rats (circles). Horizontal lines denote the group means. 
4.1.2 Hyperoxia vs. room air exposure 
Since a significant difference in the body weight (BW) was found between the groups, the 
mechanical parameters were corrected by BW. There was no evidence of a statistical 
significance in the baseline values of Raw·BW following hyperoxia exposure, whereas G·BW 
was significantly elevated in Group HC (p<0.01 vs. Group C), and H·BW was also higher in 
Groups HC (p<0.05) and HV (p<0.01) (Fig. 6.).  
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Exposure to hyperoxia significantly increased EELV in the rats in Group HC (Fig. 8B.; 
p<0.001 vs. Groups C, HS and HV), but this was blocked by the sildenafil and VIP 
treatments. 






















































































4.2 Changes in lung mechanics following bronchial challenges 
4.2.1 MCh challenges after RSD or room air exposures  
The changes in the airway and tissue parameters in the control and RSD-exposed animals 
following the MCh challenges are demonstrated in Fig. 7. MCh caused marked dose-
dependent increases in Raw, G and  (p<0.001), while the increases in H were less 
pronounced, but still statistically highly significant (p<0.001).  
The significant interactions revealed between MCh and RSD by two-way ANOVA (p<0.01) 
indicated that RSD inhalation affected the magnitude of the MCh-induced increases in Raw, 
i.e. BHR developed in the RSD group. The presence of BHR following chronic RSD 
inhalation was also reflected in the significantly lower ED100 values in the RSD group than in 
Figure 6. Mechanical parameters normalized 
to body weight (airway resistance: Raw•BW, 
tissue damping: G•BW, tissue elastance: 
H•BW) under baseline conditions, during and 
after MCh challenges (MCh 4-8-16, after 
MCh) in rats exposed to room air (Group C) 
subjected to hyperoxia without any additional 
treatment (Group HC) and hyperoxic rats 
treated either with sildenafil (Group HS) or 
VIP (Group HV). *: p<0.05 vs. Group C, #: 
p<0.05 vs. Group HC. 
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the controls (5.3±0.2 vs. 7.5±0.9 g/kg, respectively, p<0.05). The tissue parameters were not 
affected significantly by RSD inhalation (p=0.69, p=0.15 and p=0.37 for G, H and , 
respectively). 

































































Figure 7. Airway and respiratory tissue parameters measured after MCh challenges relative to the baseline (BL) 
values in the control rats (closed circles) and in rats exposed to RSD (open circles). Horizontal lines denote the 
group mean values. *: p<0.05 vs. the baseline; #: p<0.05 between the groups.  
4.2.2 MCh provocations after exposure to hyperoxia or room air 
The development of BHR was apparent from the significantly greater responses to MCh in the 
rats in Group HC (p<0.05 and p<0.001, at the second and third doses of MCh vs. Group C, 
respectively), whereas a significant reduction in the lung responsiveness to MCh was obvious 
in the hyperoxic rats treated with sildenafil (Group HS, p<0.001 at the third dose of MCh vs. 
Group C) or VIP (Group HV, p<0.001 at the third dose of MCh vs. Group C). The enhanced 
lung responsiveness in Group HC was also manifested in the significantly greater increases in 
G·BW in response to MCh (p<0.005), whereas there was no evidence of an enhanced 
response in this parameter following either sildenafil or VIP treatment. No statistically 
significant treatment-dependent differences were observed in the slight MCh-induced 
elevations in H·BW. All mechanical parameters exhibited a complete recovery by 15 min 
after the last MCh dose, with no statistically significant difference from their initial values 
(Fig. 6.).  
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The difference due to hyperoxia in the airway responsiveness to MCh  is also reflected in the 
statistically significantly decreased ED50 value (Fig. 8A) in Group HC as compared with 
Group C (p<0.01). Both sildenafil and VIP treatments significantly elevated this hyperoxia-
induced lowering in ED50 (p<0.01 and p<0.001, respectively). 
Figure 8. Equivalent doses of MCh required to cause a 50% elevation in airway resistance (ED50, panel A) and 
the end-expiratory lung volumes (EELV, panel B) measured in rats exposed to room air (Group C) subjected to 
hyperoxia without any additional treatment (Group HC) and hyperoxic rats treated either with sildenafil (Group 
HS) or VIP (Group HV). *: p<0.05 vs. Group C, #: p<0.05 vs. Group HC.  
4.3 Inflammation 










































Figure 9. Histological sections obtained in a representative 
control rat (A, left) and in another rat exposed to RSD (B, 
right) at a magnification of 10x. A/1 and B/1 are magnification 
of a pulmonary vessel, while A/2 and B/2 focus on alveolar 
regions (magnification 20x). B/3 depicts fine granular and 





Representative histological sections in lungs obtained from rats in both groups are 
demonstrated in Fig. 9. Inhalation of RSD led to the perivascular infiltration (in decreasing 
sequence of particle amount in the lymphocytes, plasma cells, eosinophils, mastocytes and 
neutrophils) and the perialveolar infiltration (in decreasing sequence in macrophages, 
lymphocytes and plasma cells) of inflammatory cells. In the alveolar areas which exhibited an 
inflammatory response, RSD particles were recovered as fine, granular and pigmented 
cytoplasmatic inclusions in the alveolar macrophages.  
4.3.2 Hyperoxia-induced inflammation 
The alterations in the cellular profile and the protein content of the BALF are outlined in 
Fig. 10. Hyperoxia led to an increased number of inflammatory cells in the BALF collected 
from the animals in Group HC (Fig. 10A, p<0.001 vs. Group C and p<0.01 vs. Groups HS 
and HV). The repartition of the cell types differed in Group HC from that in the other groups 
of rats; the percentage of PMN cells was significantly increased (Fig. 10B, p<0.001 vs. 
Groups C, HS and HV). The protein content of the supernatant was significantly elevated in 
Group HC  relative to Group C (Fig. 10C, p<0.001), while there was no evidence of a 
significant change in the sildenafil- or VIP-treated animals as compared with Groups HC 
and C (Fig. 10C).  
Figure 10. Total cells (panel A), the repartition to PMN cells (panel B) and the protein content (panel C) of the 
BALF obtained from rats exposed to room air (Group C) subjected to hyperoxia without any additional treatment 
(Group HC) and hyperoxic rats treated either with sildenafil (Group HS) or VIP (Group HV). *: p<0.05 vs. 




4.4 Lung histological changes 
4.4.1 After RSD or room air inhalation 
Figure 11. depicts the histological findings. Chronic exposure to RSD induced the 
development of mild hyperemia (p<0.05) and the mild-to-moderate infiltration of 
inflammatory cells into the perivascular (p<0.01) or perialveolar (p<0.001) areas. No 







































































































































Figure 11. Numbers of control (closed bars) and RSD-treated rats (open bars) with different severity scores 
based on the histopathological evaluations. 
 
4.4.2 After exposure to hyperoxia or room air 
The histological findings are depicted in Fig. 12. The lung sections of untreated animals 
subjected to hyperoxia (Group HC) revealed an aberrant alveolarization with decreased 
alveolar septation and consequently enlarged alveolar spaces in comparison with normoxia-
exposed lungs (Group C). These changes are expressed by the significantly increased MLI 
value (Fig. 13A, p<0.001 vs. Group C). When sildenafil (Group HS) or VIP (Group HV) 
treatment was applied concomitantly with hyperoxia, the normal alveolarization was 
preserved, as indicated by the MLI values, which exhibited no statistically significant 
difference from those for the normoxia group (Fig. 13A).  
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The 72 h of hyperoxia led to a vascular leakage, as revealed by the manifest edema around the 
pulmonary vessels (Fig. 13B). The ratio of the edema surface area to the total surface area of 
the lung sections was significantly greater in the non-treated animals exposed to hyperoxia 
than in the controls (p<0.001) or in the hyperoxia-treated rats (p<0.001 and p<0.01 vs. Group 
HS and HV, respectively).  
Figure 12. Representative images of hematoxylin/eosin-stained lung sections collected from control rats 
exposed to room air (C), rats subjected to hyperoxia without any additional treatment (HC), and hyperoxic 
rats treated with either sildenafil (HS) or VIP (HV).  



































































Figure 13. Mean linear intercept values (panel A) and percentage of edema surface (panel B) were determined 





4.5 Hyperoxia-induced apoptosis 
For each lung cryosection, the total number of nuclei and the number that were TUNEL-
positive were counted in 10 independent randomized microscopic fields, representing at least 
500 nuclei (506 to 1190); these results are presented in Fig. 14.  
Exposure to hyperoxia induced a statistically significant increase in the percentage of positive 
nuclei in Group HC relative to that in Group C (p<0.01). No evidence of statistically 
significant differences was observed in the sildenafil- or VIP-treated rats as concern the 
apoptosis in the lung cells in comparison with either the untreated hyperoxic or to the 
normoxic animals, although there were strong tendencies to increases in the relative numbers 
of TUNEL-positive nuclei in these groups. 
4.6 Results of the clinical study 
4.6.1 Basal lung functional and mechanical parameters in asthmatic children  
The children had normal basal lung function parameters with a mean percentage predicted 
value for FEV1 of 104% (range  93-136%) and a mean respiratory resistance between 4 and 
24 Hz (R4-24) of 91% (range  74-105%). 
Figure 14. Percentages of TUNEL-positive nuclei counted in lung cryosections (panel A) collected from rats 
exposed to room air (Group C) subjected to hyperoxia without any additional treatment (Group HC) and 
hyperoxic rats treated either with sildenafil (Group HS) or VIP (Group HV). *: p<0.05 vs. Group C, 
#
: p<0.05 vs. 
Group HC. Representative images for TUNEL in cryosections from the studied groups are shown in panel B. 





































































































4.6.2 Detection of BHR 
Figure 15. Lung function parameters 
obtained with spirometry (left) or 
forced oscillations (right) in individual 
asthmatic children under the baseline 
condition (BL), following inhalations 
of increasing doses of His (0.5-16 
mg/ml) and after inhalation of 
salbutamol (SA). Vertical dashed lines 




Changes observed in the spirometric and FOT parameters following His challenges are 
depicted in Fig. 15. Increasing doses of aerosolized His caused statistically significant 
decreases in the lung volume/flow indices determined by spirometry (p<0.001 for FEV1 and 
FEF25-75; p<0.05 for FVC). The parameters extracted from the real and imaginary parts of the 
Zrs spectra exhibited dose-dependent elevations after His provocation (p<0.001 for R4-24, R6 
and Fr, p<0.01 for AX). The data analyses revealed that the changes in the parameters 
determined with the FOT were statistically detectable at lower doses of His (after 0.5 mg/ml 
in R4-24, R6 and Fr; and after 2 mg/ml in AX) than those obtained by spirometry (after 1 
mg/ml in FEV1, FVC and FEF25-75). The lung function parameters obtained with spirometry 
after Sal inhalation were not significantly different from those measured at the beginning of 
the study, but the administration of Sal led to significant decreases in R6 (p<0.01) and AX 
(p<0.05), indicating that the decreases in the airway tone by the 2 agonist may be reflected in 
the FOT indices.  
Figure 16. summarizes the changes in the spirometric and FOT parameters during the MCh 
challenge protocol. Inhalation of saline following the baseline recordings did not cause 
significant changes in any of the lung function parameters (p=0.47, 0.34, 0.75, 0.98, 0.84, 
0.94 and 0.55 for FEV1, FEF25-75, FVC, R4-24, R6, AX and Fr, respectively). Inhalation of 
increasing doses of MCh resulted in dose-dependent decreases in FEV1, FEF25-75 (p<0.001 for 
both) and FVC (p<0.01). All parameters obtained with the FOT displayed dose-dependent 
significant increases following MCh inhalation (p<0.001 for all). The changes in the 
spirometric indices became statistically significant after a MCh dose of 1.0 mg/ml. Inhalation 
of even the smallest concentration of MCh (0.5 mg/ml) was sufficient to cause statistically 
detectable increases in the FOT parameters R4-24, R6 and Fr, while significant increases in AX 
were observed after a MCh dose of 1 mg/ml. Inhalation of Sal after these bronchial 
provocations totally abolished the bronchoconstrictor effects of MCh. Similarly as for His, the 
resistance parameters obtained with the FOT revealed significant decreases in the airway tone 
after Sal inhalations (p=0.002 for R4-24, p=0.006 for R6), while these changes were not 



















































































































Figure 16. Lung function parameters 
obtained with spirometry (left) or 
forced oscillations (right) in individual 
asthmatic children under the baseline 
condition (BL), following inhalations 
of normal saline (NaCl) and increasing 
doses of MCh (0.5-8.0 mg/ml), and 
after inhalation of salbutamol (SA). 
Vertical dashed lines indicate the 




4.6.3 Comparison of the parameters obtained with spirometry and FOT 
4.6.3.1 Relationships between the parameters detected 
The FEV1 values obtained with spirometry and the resistance values in the medium frequency 
range (4-24 Hz) obtained with the FOT are primarily determined by the geometry of the 
central conducting airways. Conversely, the contributions of the small airways appear in the 
spirometric FEF25-75 and the 
low-frequency resistance 
values, such as R6 (22, 47). 
Accordingly, we 
characterize the associations 
between these 
corresponding spirometric 
and FOT indices following 
the His and MCh challenges 
in Fig. 17. Following His 
challenges, strong and 
statistically significant 
correlations were observed 
between FEV1 and R4-24 
(R
2
=0.6, p<0.0001) and 
between FEF25-75 and R6 
(R
2
=0.47, p<0.0001). The 
correlations between these 
parameters following MCh 
challenges were somewhat 
weaker, but their 
associations were still close and highly significant (R
2
=0.48, p=0.0001 between FEV1 and 
R4-24 and R
2






















































































Figure 17. Correlations observed between spirometric and resistance 
parameters obtained with forced oscillations following aerosolized His (top) 




Data on the short- and long-term variabilities in the spirometric and FOT parameters are 
demonstrated in Table 1.  












FEV1 4.3 9.3 
FEF25-75 7.1 15.3 













R4-24 10.3 (6.1) 13.8 
R6 11.3 (6.2) 12.2 
AX 25.6 (17.0) 31.9 
Fr 16.7 (9.2) 25.7 
Table 1. Percentages of short- and long-term variability of the lung function parameters determined with 
spirometry or FOT in the main study group of 12 children. Values in parentheses: values obtained in 8 additional 
children where the FOT was performed without spirometry. Variability was defined as the standard deviation of 
the percentage changes between the data obtained in the first and second tests. 
The smallest variabilities were found for FEV1 and FVC, those for FEF25-75, R4-24 and R6 were 
higher, and the highest were observed for AX and Fr in the children who participated in both 
the FOT and spirometry. Substantial decreases in the short-term variability were observed for 
the FOT parameters in the 8 additional children where the FOT data were collected without 
spirometry.  
Since the variability in the FOT parameters was greater than that in the spirometric indices, 
we examined the magnitude of the changes in the resistance parameters where the His and 
MCh provocation tests became positive according to the ATS/ERS guidelines (a 20% 
decrease in FEV1 or the appearance of clinical symptoms). These data are displayed in 
Table 2. When a positive response was detected during the bronchial challenge tests, the 
changes in R4-24 were about twice as high as those in FEV1 for both of the constrictor agonists 




 Histamine Methacholine 
 R4-24 R6 Response R4-24 R6 Response 
1 38.1 59.4 W 82.0 172.8 W 
2 48.4 80.9 SW 80.9 77.6 SW 
3 53.6 124.1 W 56.9 110.4 SW 
4 16.1 24.9 SW 38.7 80.1 SW 
5 37.0 53.4 SW 39.7 51.6 SW 
6 41.5 -1.5 W 30.8 38.8 W 
7 64.9 107.8 SW 53.6 76.1 SW 
8 46.8 48.3 SW 28.9 36.8 SW 
9 66.9 116.8 SW 7.1 20.0 SW 
10 25.8 46.7 SW 5.2 17.3 W 
11 12.3 27.3 SW -5.3 5.94 SW 
12 20.7 40.4 W 40.8 54.4 W 
13 5.9 5.5 SW -2.7 19.8 SW 
14 16.3 31.0 SW 30.8 62.4 SW 
15 27.7 23.6 W 2.9 11.3 W 
16 34.8 11.1 SW 24.1 41.0 SW 
17 38.6 58.0 SW 11.4 8.1 SW 
18 23.4 23.1 W 12.8 9.9 SW 
19 7.0 23.2 SW 10.7 28.3 SW 
20 15.5 40.9 W 46.9 43.4 SW 
Mean 32.1 48.9  27.6 49.7  
 
Table 2. Percentage changes in the resistance parameters where the His and MCh provocation tests became 
positive according to the ATS/ERS guidelines (a 20% decrease in FEV1 or the appearance of clinical 




4.6.3.3 SD indices 
The SD indices for the changes in the lung function parameters following the His and MCh 
challenges (determined with spirometry and the FOT) are presented in Fig. 18. Data are 
shown for the lower part of the dose-response curve, where measurements were made for the 
majority of the children (i.e. prior to a 20% decrease in FEV1 or the appearance of clinical 
symptoms).  The sensitivity of the FOT parameter R4-24 was greatest following both His and 
MCh challenges. R6 and FEF25-75 exhibited similarly high sensitivities in the detection of His- 
or MCh-induced airway narrowing. The parameters AX, Fr, FEV1 or FEF25-75 also 
demonstrated bronchoconstriction after His and MCh challenges, but only after the second 










































Figure 18. SD index of the lung function parameters obtained with spirometry (filled symbols) and 
forced oscillations (open symbols) following His or MCh challenges. *: p<0.05 vs. FEV1 within a dose, 




Airway susceptibilities involving BHR are posing an increasing worldwide challenge for 
health professionals. The studies included in the present thesis focus on the environmental 
factors involved in the pathogenesis of BHR in animal models. Airway irritations leading to 
chronic inflammation may result from the inhalation of airborne particles and/or an altered O2 
content of the inspired gas mixture. Treatment of BHR related to asthma has been well 
established by inhibiting the inflammation and by affecting the receptors responsible for the 
regulation of the airway tone. However, treatment strategies for hyperoxia-induced lung 
damage that may also induce BHR have not been completely characterized. Thus, interest has 
emerged in protection against the adverse pulmonary effects of O2 toxicity. Since the first 
symptoms of asthma are revealed before school age, a clinical protocol was designed to detect 
BHR in asthmatic children by using a novel measurement technique that can be applied in 
pre-schoolers. 
5.1 Animal models 
5.1.1 Lung mechanics in animal models 
5.1.1.1 Effects of RSD on basal lung function and lung hyperresponsiveness 
Despite the high RSD concentration (peak/minimum concentration in the exposure chamber: 
~1/7 mg/m
3
) and the evidence that it accessed the lower respiratory tract, no clinically 
significant adverse changes in the baseline airway or respiratory tissue mechanics were 
detected (Fig. 5.). The tendency to higher G and H in the animals in the RSD group may be a 
consequence of the mild inflammation demonstrated by the lung histology (Fig. 11.). The 
development of airway inflammation is in accord with previous findings on animals exposed 
to high concentrations of inhalable particles originating from carbon black (45, 53), ultrafine 
titania (66), urban air pollution (17, 33), and fine particulate matter arising from the 
destruction of the World Trade Center (26). Since merely mild airway inflammation has no 
major effects on the basal lung function (17, 65, 71, 84), the lack of difference between the 
two groups is consistent with the previous results.   
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In agreement with previous findings that inhaled particulate matter induced asthma-like 
symptoms (17, 42, 45, 56, 63, 84, 92), the chronic airway inflammation that occurred 
following RSD inhalation led to the development of BHR, which was manifested in 
significantly elevated responses to MCh (Fig. 7.) and subsequent decreases in ED100. As 
concerns the mechanism of the emergence of BHR, the involvement of macrophages can be 
anticipated from the histological findings (Fig. 9 and 11), since the role of alveolar 
macrophages in the development of an inflammation response in the small airways was 
evidenced previously (56, 67). Acute inflammation is probably caused by the phagocytosis of 
inhaled particles by alveolar macrophages and the release of inflammatory mediators from 
these cells. This injury response already appears within a few hours after inhalation and is 
particle size-dependent: the most destructive particles are the ultrafine ones (<50 nm), which 
are able to pass into the phagocytes (57). Since a substantial proportion of the particles in our 
study were in this size range, the involvement of this mechanism is expected. Chronic dust 
inhalation drives the influx of macrophages and other inflammatory cells, and these factors 
may lead to the progress of chronic lung diseases such as asthma (2, 17), emphysema, 
bronchiolitis (27) or fibrosis (67).  
5.1.1.2 Respiratory function and lung responsiveness after hyperoxia exposure 
In accordance with earlier results when immature rats were exposed to O2 for a short time 
(34),  the basal Raw was not affected by hyperoxia exposure (Fig. 6.); this is also in line with 
the notion that Raw is determined primarily by the geometry of the central conducting 
airways, which remained unaffected (28, 72, 85). An airway obstruction was detected in 
earlier studies when exposure to O2 was applied for a prolonged period (e.g. 4 weeks), which 
was sufficient for airway remodeling to develop (89).  
The 72-h exposure to hyperoxia resulted in increases in the basal values of both viscoelastic 
tissue parameters (Fig. 6; G·BW and H·BW), which accords with the results of previous 
studies where a decreased compliance was found after the application of O2 toxicity (5, 28, 
87, 89). Since the hyperoxia-induced increases in G·BW and H·BW were proportional, the 
enhancement of ventilation heterogeneities was not likely to have played a role in these 
findings (55). It seems more probable that perivascular and interstitial edema formation is 
responsible for these proportional elevations, this being substantiated by the histological 
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findings (Fig. 13B) and the elevated protein level in the BALF (Fig. 10C). Nevertheless, other 
processes may also have been involved in the increase in H·BW, since an elevation in 
elastance was also observed in the VIP-treated rats, despite the lack of manifest edema. Such 
processes may be related to hyperventilation throughout the exposure, striving to compensate 
the hyperoxia and causing hypertrophy of the intercostal muscles, leading to stiffening of the 
entire respiratory system.  
Our findings demonstrate the development of lung hyperresponsiveness as early as 72 h after 
the onset of hyperoxia, manifested in a decreased ED50 value (Fig. 8A), in accordance with 
the results of the few previous studies where bronchoprovocation tests were performed (14, 
34, 87).  It is noteworthy that this functional abnormality is already present despite the lack of 
remodeling of the bronchial wall at this early stage of O2 toxicity (85). Both sildenafil and 
VIP compensated and even overcompensated the enhanced lung responsiveness by 
stimulating endogenous NO production in the lungs. The excessive NO level may explain the 
diminished airway responsiveness by exerting the relaxation potential of the bronchial smooth 
muscle, which then leads to a decreased response relative to that in naïve animals. Since 
exposure to hyperoxia causes adverse alterations in the lungs at functional, structural and 
molecular levels, we characterized whether the prevention of functional abnormalities by 
stimulating the NO pathway is due to maintenance of the normal lung structure and 
biochemical profile. 
5.1.2 Mechanisms underlying BHR following hyperoxia exposure 
5.1.2.1 Inflammation 
It is generally considered that inflammation and the influx of leukocytes play major roles in 
severe hyperoxia-induced lung injury (51). Leukocyte infiltration involving mainly 
macrophages and neutrophil granulocytes (62, 70, 81) leads to a demonstrable accumulation 
in the alveolar space even after an exposure to hyperoxia of only 12 h (62). We found similar 
results in our model (Fig. 10). Since the inflammation is of great importance in the 
development of hyperoxia-induced lung damage, and as the inflammatory cells appear in the 
first few hours of hyperoxia exposure, early inhibition of the inflammatory response might 
prevent the lung injury. A further consequence of hyperoxia-induced cell damage is the loss 
of integrity of the alveolar-capillary barrier, resulting in an alveolar leak, which then causes 
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increased exudation in the alveolar spaces (7, 81) and an increased protein level in the BALF 
(Fig. 10C). VIP was previously shown to protect alveolar epithelial cells against hyperoxia 
via the activation of the signal transducers and activator of transcription 3 (3, 4) and the 
overexpression of several survival genes (50). This results in capillary leakage retardation and 
a decreased neutrophil influx (Fig. 10A,B) into the lung. These findings may be attributed to 
the preserved NO activity, which can maintain the normal clearance of edema fluid in the 
lungs (74). Thus, treatment with sildenafil or VIP offers effective protection against the 
deleterious inflammatory events in the lungs by inhibiting PMN cell infiltration into the 
alveolar compartment and reducing the consecutive tissue destruction and pulmonary edema 
caused by hyperoxia. Overall, lung inflammation with low levels of bronchodilatory NO 
production, and alveolar destruction with a subsequent decrease in mechanical support to the 
small airways, are responsible for the enhancement in lung responsiveness. 
5.1.2.2 Lung morphology  
Recent results suggested the importance of the vascular endothelial growth factor (VEGF) in 
normal lung development: inhibition of VEGF led to abnormal alveolarization in neonatal 
rats, while VEGF therapy during hyperoxia maintained the normal alveolarization (76, 80). 
Furthermore, a decreased VEGF level in hyperoxia may contribute to insufficient NO 
production and, vice versa, a disturbance of the NO/cGMP pathway also exerts a negative 
effect on the VEGF activity (70). In our hyperoxia model, the 72-h exposure to O2 was 
sufficiently long for an abnormal alveolar structure to be observed in the developing lungs 
(Fig. 12). Compensation of the decreased NO activity, either through stimulation of the 
cGMP-dependent effects by using sildenafil to activate VEGF (70), or through enhancement 
of the NO production by VIP treatment was able to preserve the normal lung development 
despite maintenance of the hyperoxic environment (Fig. 12). MLI measurement confirmed 
that enlarged alveolar spaces were observed only in the non-treated O2 -exposed animals; in 
the other groups, the MLI data were normal. This finding points to a preserved physiological 
alveolar structure (Fig. 13A).  
5.1.2.3 Changes in lung volume 
The changes in lung architecture were also reflected in the hyperoxia-induced EELV 
elevation in Group HC (Fig. 8A).  In this emphysematous condition, air is trapped in the 
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enlarged alveolar spaces at end-expiration and the gas content of the chest is increased. 
Moreover, the small airways are likely to display a tendency to collapse during expiration due 
to their structural impairment, and their function may be further compromised by the 
decreased elastic support of the damaged lung parenchyma, which would be less able to keep 
the small airways open. Since the sildenafil and VIP treatments prevented the adverse 
alterations in the alveolar structure, the EELV must have remained normal in these animals.  
5.1.2.4 Alveolo-capillary disruption 
Elevated amounts of ROS are known to cause alterations in DNA and proteins and are the 
major contributors to alveolar cell death in hyperoxia (7, 13). Alveolar cell death is an early 
event in hyperoxia-induced lung injury (7, 44). In agreement with the literature finding, the 
number of apoptotic/necrotic cells in the rat lungs was elevated following exposure to 
hyperoxia for 72 h (Fig. 14). However, there was no evidence that sildenafil or VIP could 
prevent apoptosis and necrosis (Fig. 14), suggesting that these treatments are unable to 
counteract the early ROS injuries, which are the initial mechanisms in the influx of 
inflammatory cells. 
5.2 Detection of BHR in children 
Since the  introduction of the FOT  by Dubois et al. in 1956 (18) and its extension towards the 
application of a wide frequency range of pseudorandom pressure excitation (46), the 
popularity of this lung mechanical measurement technique has increased, particularly as 
concerns examinations on patients with a limited ability to cooperate (12, 19, 22-24, 29, 30, 
43, 48, 49, 58, 68, 77, 88, 90, 94). This beneficial profile of the FOT allows the 
characterization of lung function abnormalities in children with various respiratory diseases, 
such as cystic fibrosis (23, 24, 49, 77, 88), neonatal chronic lung disease (88, 90), wheezy 
bronchitis (68, 88, 94, 95) or asthma (12, 29, 43, 64, 88). Furthermore, the FOT has been used 
successfully to characterize bronchodilator responsiveness (58, 68, 88) and to detect lung 
function changes following the inhalation of a bronchoconstrictor agonist in children (29, 43, 
94, 95). However we are aware of only a few previous studies in which the sensitivities of the 
FOT and spirometry were compared with regard to the detection of BHR in asthmatic 
children (12, 19, 48), when the bronchial challenges were performed in accordance with the 
ATS guidelines (16). Even those earlier studies lack a comprehensive analysis of the 
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sensitivities of the lung function parameters with consideration of the differences in 
variability of the techniques applied. Since spirometry is a  routine procedure in lung function 
laboratories for the detection of BHR in the diagnosis of asthma, demonstration of the similar 
ability of the FOT is of major importance, since this technique can be  carried out reliably  in 
a much younger age group (as low as 2 years of age (43, 64)). Nevertheless, children of 
school age were enrolled in the present study, in order to allow a comparison with spirometry.  
5.2.1 Relationships between the parameters obtained with the FOT and spirometry 
Strong and highly significant correlations were observed between the corresponding FOT and 
spirometric parameters relating to the larger (FEV1 vs. R4-24) and smaller airways (FEF25-75 vs. 
R6), which suggests that airway narrowing is faithfully reflected by both techniques (Fig. 17.). 
Nevertheless, the correlation analysis does not take into account the variability of the 
measured parameters, which is of great importance in a comparison of the ability of a lung 
function test to measure bronchoconstriction with subsequent promise to detect BHR. 
Previous studies have established that lung function parameters obtained by measurement 
techniques utilized during tidal breathing exhibit somewhat greater variability than those 
based on  forced expiration (23). In accordance with that finding, we experienced greater 
short- and long-term variabilities for the FOT parameters than those measured with 
spirometry. This implies that greater magnitudes of changes can be regarded as positive 
responses in the FOT parameters (Table 2), which corresponds to previous observations (10, 
29, 94) and recommendations for higher acceptance limits of clinically important changes 
(10). 
5.2.2 SD indicies 
In order to take the greater magnitudes of the changes in the FOT parameters into account, the 
alterations in the lung function indices following the His and MCh challenges were also 
expressed in SD indicies (Fig. 18). This analysis revealed comparable SD indicies for the lung 
function parameters determined with the FOT and spirometry in the detection of airway 
narrowing following both the His and the MCh challenges. However, there was a tendency to 
a greater sensitivity of the FOT parameters relating to the low-frequency part of the Zrs 
spectra, which was particularly evident for AX. Since AX is extracted from the low-frequency 
reactance, it primarily reflects changes in the elasticity of the total respiratory system. It 
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therefore seems likely that, besides inducing a constriction of the conducting airways 
manifested in elevated forced expiratory lung volumes and resistance parameters, the 
inhalation of the bronchoconstrictor agonists also led to a stiffening of the respiratory tissues. 
The most probable mechanism responsible for such a change in the respiratory elasticity is the 
loss of lung volume via the development of air trapping, due to the uneven deposition of the 
bronchoprovocation agonists, which was earlier clearly demonstrated following challenges 
with aerosolized His (60, 75). The lack of a significant decrease in FVC despite this loss of 
lung volume may be related to the forced deep inspiration to the total lung capacity prior to 
the expiration, which has been demonstrated to be likely to reopen the compromised lung 
regions (60).
 
5.2.3 Effects of deep inspiration on the lung fuction 
As concerns the greater variabilities in the parameters determined with the FOT than those 
with spirometry, the sequence of the tests in the present experimental setting warrants 
consideration. Since the FOT requires normal quiet breathing only, it has no influence on the 
spirometric outcome. This sequence of the tests ensured the minimal interaction between the 
two lung function tests. Nevertheless, the deep inspiration and subsequent forced expiration 
maneuvers necessary for spirometry may affect the lung mechanics, which may be manifested 
even 5 min later in the FOT recordings. In addition to the potential diminution of the lung 
functional changes that results from the deep inspirations homogenizing the lung periphery 
(60), these forced breathing maneuvers may also widen the short-term variability of the FOT 
parameters obtained in the present study, which then ultimately affect the SD index extracted 
from the Zrs spectra, and hence the sensitivity of the tests. To test this hypothesis, we 
recruited 8 asthmatic children of school age on whom two sets of baseline FOT recordings 
were performed 5 min apart, without spirometry between them. The SD index decreased 
substantially (Table 1), suggesting that the sensitivity of the FOT test for the detection of 
BHR can be potentially doubled if the measurements are performed without additional lung 
function tests requiring special breathing maneuvers. It is noteworthy that, even with the 
apparently increased variabilities in the FOT indices, the resistance parameter R4-24 was the 
most sensitive in the detection of BHR, since the SD index of this parameter exhibited 
significant increases after the first dose of both His and MCh.  
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6 SUMMARY AND CONCLUSIONS 
We investigated the influence of environmental factors on the development of BHR in inbred 
animals, which excluded the effects of various genetic factors. We demonstrated the 
development of pulmonary inflammation and subsequent BHR following airway irritations in 
animal model studies. We also demonstrated the feasibility of detection of BHR in children of 
school age by using a technique that requires minimal patient cooperation. In all studies 
included in the present thesis, the basal airway mechanics was unaffected be the altered 
environment, while the elevated constrictor response of the airway smooth muscle following 
the application of bronchial challenges was proved by measuring airway properties with the 
FOT. Specifically, the findings of the present thesis contributed to the following particular 
research topics: 
 The effects of RSD produced from an on-site sample in the Ajka region on the 
pulmonary system were assessed in an animal model by performing basal lung 
function measurements, with the assessment of changes in lung responsiveness and 
also histopathological analyses. When rats were chronically exposed to a high 
concentration of RSD, the fine powder particles reached the lower respiratory tract, 
but the alterations in the basal airway and respiratory tissue mechanics were not 
significant. The mild inflammation that developed around the pulmonary vessels and 
in the alveolar wall was associated with a mild BHR. Since these mild respiratory 
symptoms emerged following exposure to extremely high concentrations, our results 
may suggest that the short-term health hazard as regards the pulmonary system in 
healthy human adults exposed to RSD inhalation is not greater than that due to urban 
dust at a comparable concentration. 
 In our short-term hyperoxia exposure model, duration of 72 h was sufficient to induce 
adverse molecular, morphological and functional changes in the lungs. Although no 
evidence was found that sildenafil and VIP treatments prevented the initial apoptotic 
changes in the lungs, both treatments were able to maintain the normal alveolar 
structure, inhibit the development of edema and inflammation, and prevent the 
consequential lung function deterioration by enhancing the activity of NO-mediated 
pathways involved in the lung damage following hyperoxia. Our findings therefore 
45 
 
point to the potential benefit of sildenafil or VIP treatment in the critical acute phase 
of hyperoxic lung damage, and such treatment should be considered as one of the 
possible strategies designed to prevent the irreversible functional and structural 
changes in the developing lungs. 
Since the detection of BHR poses an increasing clinical challenge in patients with limited 
abilities to cooperate, a clinical study was designed to determine the efficiency of the FOT in 
the detection of BHR following bronchoprovocation tests in asthmatic children. Our clinical 
findings suggest that 
 the resistance and reactance parameters determined with the FOT revealed airway 
constriction at smaller doses of the agonists than those needed in standard spirometry;  
 with regard to the greater variability in the FOT parameters when the FOT is 
performed concomitantly with spirometry, the two lung function measurement 
methods have similar sensitivities in the assessment of BHR;  
 if the FOT is performed alone, the short-term variability of the resistance parameters 
decreases markedly and approaches that observed for the spirometric indices.  
In summary, the studies included in the present thesis contribute to a better understanding of 
the BHR that develops in an altered environment by pointing to the complex involvement of 
inflammatory and cellular mechanisms leading to structural and functional abnormalities. Our 
clinical study reveals that the use of the FOT may impose less stress on the tested children 
and may lead to a decrease in the age at which BHR can be detected, so that asthma can 
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a  b  s  t  r  a  c  t
The  environmental  disaster  following  ﬂooding  by  red  sludge  in the  Ajka  region  in Hungary  poses  a  serious
public  health  threat  with  particular  concern  regarding  the potentially  adverse  respiratory  effects  of the
inhalation  of red  sludge  dust  (RSD).  The  respiratory  consequences  of  the inhalation  of  RSD  obtained  from
ﬁeld  samples  were  investigated  in  rats.  Rats  were  either  exposed  to RSD  at a high  concentration  (2 weeks,
8  h/day),  or  kept  in room  air. After  the  exposures,  the  airway  resistance  (Raw)  and  the  respiratory  tissues
mechanics  were  measured  under  baseline  condition,  and  following  methacholine  (MCh)  challenges  with
the aim  of  establishing  airway  hyper-responsiveness  (AH).  Histopathology  was  performed  to  assess  lung
morphologic  alterations.  The  physical  properties  and  the  chemical  composition  of the  RSD  were  also
characterized.  The  size  distribution,  chemical  composition  and  topology  of  the  RSD  particles  applied  in
our experiments  were  similar  to those  observed  at the site  of  the  disaster.  The  inhalation  of RSD  did not
alter  the  basal  respiratory  mechanics,  whereas  it led  to greater  MCh-induced  responses  in  Raw,  demon-
strating  the  progression  of  mild  AH. Histopathological  investigations  revealed  ﬁne,  granular  particles  in
the alveolar  macrophages,  as evidence  that  RSD  had  reached  the  lower  respiratory  tract  and  induced
mild  inﬂammation  around  the  alveoli  and  the  pulmonary  vasculature.  The  mild  respiratory  symptoms
that  developed  following  short-term  exposure  of healthy  individuals  to high  concentrations  of  airborne
RSD do not  appear  to  pose  a  greater  respiratory  hazard  than  the  inhalation  of urban  dust  at  a comparable
concentration.
© 2011 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
The pond dam of a red sludge reservoir of an alumina plant
near Ajka, in the west of Hungary, burst on October 4, 2010. The
600,000–700,000 m3 of toxic red sludge that streamed out from the
damaged ﬂooded 3 towns and affected 4 other residential areas,
in some places in a depth of up to 2 m,  and rapidly covered an
agricultural area of about 40 km2 (http://redsludge.bm.hu, 2011.
Ofﬁcial Website of the Hungarian Government). This catastrophe,
as one of the worst environmental disasters in Europe, caused the
death of 10 persons, and hundreds of others suffered major injuries,
mainly burns from direct contact with the highly alkaline (pH ∼ 13)
material (Gelencser et al., 2011).
Even after the immediate critical phase of the sludge pill had
passed, the potential hazards posed by constituents of the red
∗ Corresponding author. Tel.: +36 62 545077; fax: +36 62 545077.
E-mail address: petak@dmi.szote.u-szeged.hu (F. Peták).
sludge continue to raise severe public health concerns (Ruyters
et al., 2011). Health professionals agree that the most important
health risk is related to inhalation of the dust formed when the red
sludge dries and its particles are swept into the atmosphere by the
wind. Since the air may  also be contaminated with red sludge dust
(RSD) if the common dry storage method is used for the deposition
of this byproduct, this environmental threat may also involve work-
ers or inhabitants in regions neighboring plants where alumina is
produced from bauxite by the Bayer process.
Despite the potential health hazards posed by the inhalation
of RSD, the likelihood of its adverse affects in the respiratory sys-
tem have previously been assessed only by examining the chemical
and physical properties of red sludge particles (Gelencser et al.,
2011). These measurements indicated that the particle size of the
RSD examined was  larger than the critical size capable of reaching
the alveolar compartment. Nevertheless, the fugitive dust particles
may  still reach and subsequently irritate the epithelium in both
the central and peripheral airways (Dong et al., 2005; Fernvik et al.,
2002; Kilburn, 1984; Li et al., 1997). Accordingly, an investigation
0378-4274/$ – see front matter ©  2011 Elsevier Ireland Ltd. All rights reserved.
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Fig. 1. Experimental setup for RSD exposure.
is warranted in which the effects of prolonged exposure to RSD are
examined in an animal model; such results may  contribute greatly
to clariﬁcation of the potential respiratory complications.
The primary aim of the present study, therefore, was a system-
atic investigation of the consequences of prolonged RSD inhalation
on the airway and respiratory tissue mechanics in rats. Consid-
eration was given to potential histopathological alterations in
the lungs. Since the airway irritation following the inhalation of
ambient particulate matter contributes to an increased preva-
lence and exacerbations of asthma (Dong et al., 2005; Kilburn,
1984; Lambert et al., 2003; Nel et al., 2001; Wang et al., 2008),
we also set out to explore whether RSD exposure leads to air-
way hyper-responsiveness (AH), which is the hallmark feature of
asthma.
2. Materials and methods
2.1. Exposure to RSD
The experimental protocol was approved by the Experimental Ethics Commit-
tee  of the University of Szeged (I-74-17/2010) and the Animal Health and Welfare
Ofﬁce of the local authorities in Hungary. Certiﬁed red sludge samples were obtained
from the local ofﬁce of the National Directorate General for Disaster Management
in Devecser 10 days after the disaster. The red sludge was dried in an oven at 60 ◦C
for  24 h and the resulting dry material was mechanically ground to form a powder
containing ﬁne particles able to furnish a cloud of dust in an airﬂow. The particle
size distribution was determined (see below). The resulting RSD was  then placed in
a  sealed glass container with two tubes passing through its lid (Fig. 1). The internal
end of one of these tubes was  immersed in the RSD and the other end was  attached
to  the inspiratory port of a small animal ventilator (model 683, Harvard Apparatus
Co. Inc., South Natick, MA, USA). The internal end of the other tube was  kept above
the RSD while the other end was  connected to the inlet of the exposure chamber.
This  system cyclically raises a cloud of dust in the RSD container during the inspi-
ratory phases of the ventilator. The airborne ﬂow of RSD by wind was mimicked by
shaking the glass container containing the RSD for 20–30 s every 60–90 min, which
intensiﬁed the access of particles to the inspiratory port and subsequently increased
the  RSD concentration in the exposure chamber. Since the ventilator frequency was
maintained at 50 strokes/min with the stroke volume set at 30 ml  during exposure,
this apparatus ensured the supply of fresh ambient gas into the exposure cham-
ber,  which contained a maximum of 5 animals at a time. The exposure chamber
was  connected to the atmosphere via a disposable bacterial ﬁlter in order to avoid
contamination of the room air with RSD particles.
Two groups of male Wistar rats were studied (weight range 350–455 g). The
animals in the RSD group were exposed to RSD in the exposure chamber for 8 h
a  day for 2 weeks (N = 10). The animals in the control group were kept in another
chamber with identical dimensions and underwent the same procedure except that
they were allowed to breathe dust-free room air (N = 11). The rats in both groups
had access to food and water ad libitum throughout the entire exposure period.
2.2. Assessment of RSD concentration
To determine the concentration of respirable particulate matter (<10 m aero-
dynamic diameter; PM10), the tapered element oscillating microbalance (TEOM)
technique (Series 1400a, Rupprecht and Patashnick Co. Inc., Albany, NY, USA) was
used. This instrument allows quasi-continuous monitoring of the mass of PM10 accu-
mulating on a ﬁlter mounted on an oscillating balance inside the measurement
apparatus (Kinghama et al., 2006). Changes in the frequency of oscillation reﬂecting
the  mass of material accumulating on the ﬁlter are detected in quasi-realtime and
converted by a microprocessor into an equivalent PM mass concentration every few
seconds with a 10-min running average. The TEOM air stream was  heated to 40 ◦C
to  prevent the condensation of water vapor on the collected samples, the non-water
semivolatile mass loss being kept at a minimum (Aberkane et al., 2004).
2.3. Measurement of RSD particle size distribution
2.3.1. Measurements below 300 nm
A  scanning mobility particle sizer (SMPS) consisting of a differential mobility
analyzer (Model #5.400, with Classiﬁer “Vienna”-Type DMA) and a condensation
particle counter (Model #5.500, Grimm Aerosol Technik, Ainring, Germany) was
used to measure the particle size distribution below 300 nm.  The sheath and aerosol
ﬂow rates were set to 3.0 and 0.3 l/min, respectively, which allowed measurements
of particles with electrical mobility diameters between 5.5 and 350 nm.
2.3.2. Measurements above 300 nm
An optical particle counter (Model 1.109, Grimm Aerosol Technik, Ainring,
Germany) was  used for real-time characterization in the particle size range above
300 nm (Heim et al., 2008). This device uses a 683-nm laser diode to illuminate the
beam containing the particles, and a wide-angle collector optic is used to detect the
subsequent light pulses with a photodiode. The optical arrangement (mean scat-
tering angle 90◦) collects the scattered light with a parabolic mirror (120◦) on one
side and an additional 18◦ on the opposing side. The wide-angle optic increases the
total amount of scattered light detected by the photosensor close to the Rayleigh
scattering domain. This improves the signal to noise ratio, which leads to a decrease
in  the minimum particle size that can be detected (speciﬁed by the manufacturer
as 205 nm). The optical counter readings were corrected by a method suggested
previously (Gelencser et al., 2011).
2.4. Determination of RSD topology and composition
RSD was  collected on double-sided adhesive carbon tape, and the topology and
approximate composition were subsequently examined with a scanning electron
microscope (Hitachi-S4700, 20 kV acceleration voltage) at various magniﬁcations
(1000–25,000×). Energy-dispersive X-ray spectroscopy (EDX) data were obtained
with a Röntec QX2 energy-disperser microanalytical system (Röntec GmbH, Berlin,
Germany) from various parts of the sample for elemental composition identiﬁcation.
2.5. Measurement of airway and respiratory tissue mechanics in rats
Airway and tissue mechanics was  characterized by measuring the forced oscilla-
tory  input impedance of the respiratory system (Zrs), as detailed previously (Novak
et al., 2006; Petak et al., 1997). Brieﬂy, the respirator was stopped at end-expiration,
and the tracheal cannula was connected to a loudspeaker-in-box system during the
resulting 6-s apneic period. The loudspeaker generated a small-amplitude pseu-
dorandom forcing signal in the frequency range 0.5–21 Hz. The excitation signal
was led through a polyethylene wave-tube (L = 100 cm, ID = 2 mm); lateral pressures
were measured at both ends of the tube with two identical pressure transducers
(model 33NA002D, ICSensors, Milpitas, CA, USA), and Zrs was  determined as the load
impedance of the wave-tube (Van de Woestijne et al., 1981). The airway and tissue
parameters were estimated separately by ﬁtting a model to the Zrs spectra via mini-
mization of the relative differences between the measured and modeled impedance
values. The model contained a frequency-independent airway resistance (Raw) and
inertance (Iaw) in series with a constant-phase tissue compartment (Hantos et al.,
1992)  characterized by the coefﬁcients of tissue damping (G) and elastance (H).
The  parameter Raw characterize the resistance of the treacheobonchial tree against
airﬂow, while Iaw is related to acceleration and deceleration of air in the bronchi;
tissue parameters G and H reﬂect dissipative (resistive) and energy storage (elastic)
properties of the respiratory tissues (Hantos et al., 1992). Respiratory tissue hys-
teresivity () reﬂecting the coupling between energy dissipation and storage within
the  respiratory tissues was calculated as G/H (Fredberg and Stamenovic, 1989). The
impedance of the tracheal cannula and the connecting tubing was measured after the
experiments; the Raw and Iaw values were corrected by subtracting the instrumental
resistance and inertance values from them.
2.6. Experimental protocol
On the days of the experiments, anesthesia was  induced in both groups of rats
with an ip injection of 5% chloral hydrate at a dose of 400 mg/kg, which ensures
adequate anesthesia for 50–60 min  (Novak et al., 2006). Endotracheal intubation was
performed with a method developed for small rodents (Brown et al., 1999) with the
rat suspended at an angle of 45◦ by its two  front upper teeth, and transillumination of
the trachea just below the vocal cords was  achieved by using a 150-W halogen light
source (Nicon Volpi Cold Light Illuminator, Nikon Instruments Inc., Tokyo, Japan)
connected to a ﬂexible ﬁber optic arm. During this direct visualization, a 7.0-cm-long
(ID 1.5 mm,  OD 2.0 mm)  polyethylene catheter was  inserted into the trachea via the
oral cavity with the help of a Draeger baby laryngoscope. The rat was then removed
from the Plexiglas support, placed in a supine position on a heating pad, and the distal
end  of the tracheal cannula was  attached to a small-animal ventilator (Model 683,
Harvard Apparatus, South Natick, MA,  USA). The rats were mechanically ventilated
with room air with frequency set to 70 breaths/min and 7 ml/kg tidal volume. The
tail  vein was cannulated with a 24-gauge cannula (Vygonüle V 24G), and muscle
relaxation was achieved by administering pancuronium bromide (0.2 mg/kg iv).
When the animal had reached a steady-state condition (5–10 min  after the
starting of mechanical ventilation), the volume history was standardized by
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administering a hyperinﬂation via occlusion of the expiratory port of the venti-
lator. Three technically acceptable Zrs recordings were then collected to establish
the baseline respiratory mechanical parameters. An iv bolus of methacholine (MCh)
at  a dose of 2 g/kg was  next administered into the tail vein, and Zrs was  recorded
20  s, 1 min  and 2 min  after the injection. Previous experiments revealed that the
peak response occurs at 20 s after the MCh injection, and the effect is diminished
2  min  later (Novak et al., 2006). Following this transient constriction the animal was
allowed to recover, and further iv MCh  challenges were given with elevation of the
MCh  dose to 4, 8 and 16 g/kg. The peak increases in the mechanical parameters
were observed 20 s after the MCh  injection; these increases were related to those
obtained from the average of the three baseline Zrs recordings.
2.7. Lung histopathological examinations
After completion of the bronchoprovocation tests, the rats were euthanized with
an  iv injection of 10% KCl. The chest was opened by midline sternotomy, and the
lungs were ﬁlled with 4% buffered formalin by applying a hydrostatic pressure of
20  cm H2O. The lungs and heart were then removed in one block and placed into 4%
buffered formalin until processing.
Representative lung tissue sections (from the mid  portion of both lungs) were
embedded in parafﬁn blocks. Transhilar horizontal sections (perpendicular to the
longitudinal axes of the lung from the hilum) were embedded in parafﬁn. Two
5-m  sections were prepared in each lung specimen and were stained with
hematoxylin–eosin. All slides were examined by the same investigator in a blind
fashion and random sequence. A lung injury score was  used to quantify the changes
in  lung morphometry observed under a light microscope. The degree of microscopic
injury was  scored with regard to the following variables: blood congestion (hyper-
emia), inﬁltration of perivascular and perialveolar inﬂammatory cells (lymphocytes,
plasma cells and macrophages), and the presence of bronchus-associated lymphoid
tissue (BALT) or its hyperplasia. The severity of injury was graded as follows for each
of  the four variables: no injury (None), injury involving up to one-third of the ﬁeld
(Mild), injury involving up to two-thirds of the ﬁeld (Moderate) and diffuse injury
throughout the ﬁeld (Severe).
2.8. Statistical analyses
Scatters in the parameters were expressed in SE values. The MCh  dose causing
a  100% increase in Raw (ED100) was calculated by linear interpolation of the dose-
response curves from the individual animals. The Kolmogorov–Smirnov test was
used to test data for normality. The t-test was  utilized to estimate the effects of
RSD exposure on the basal respiratory mechanical parameters and on the ED100
values. Two-way repeated measures analysis of variance (ANOVA) was used with
the  variables RSD exposure and MCh  dose to establish the effects of RSD on the
lung responsiveness. The Student–Newman–Keuls multiple comparison procedure
was  employed to compare the respiratory mechanical parameters under different
conditions. Since the histological data were not distributed normally, the Wilcoxon
signed rank test was  used to compare these ﬁndings between the protocol groups.
The  statistical tests were performed with a SigmaPlot software package (version 11,
Systat Software Inc., Chicago, IL, USA). In each test, a signiﬁcance level of p < 0.05
was  applied.
3. Results
A typical change in the concentration of RSD in the exposure
chamber is illustrated in Fig. 2. Mimicking a gust of wind by shak-
ing the RSD container caused a rapid increase in the amount of
RSD in the air in the exposure chamber, which reached a peak
concentration of ∼7 mg/m3. The concentration of RSD then grad-
ually decreased, with the minimum amount of RSD approaching
∼1 mg/m3. The mean RSD concentration during exposures was
3.3 mg/m3.
The RSD particle size distribution before and immediately after
the win-mimicking maneuver and the average for a complete expo-
sure period are depicted in Fig. 3. The peak of the log-normal
distribution during the overall exposure period was at 150 nm,  with
a detectable amount of particles observed in the range 20 nm to
5 m.  There was a temporary shift to higher particle sizes after
the win-mimicking maneuver, but a smaller particle dominated the
RSD thereafter.
The analyses of the chemical composition of the RSD aggregates
revealed the predominance of oxygen (55.4 ± 2.8%) in all 5 samples
analyzed. Among the remaining chemical elements, Fe was  present
in the greatest quantity (20.1 ± 4.9%), followed by Al (8.6 ± 3.4%),
Ca (6.0 ± 3.2%), Si (3.9 ± 1.1%), Ti (3.7 ± 1.4%), K (2.1 ± 0.7%) and Mg
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Fig. 2. Changes in RSD concentration during exposure. Cyclic increases in the con-
centration were induced by shaking of the glass container containing the powder
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Fig. 3. RSD particle size distribution before and immediately after the win-
mimicking maneuver, and the average for the overall exposure period.
(0.19 ± 0.16%) (Fig. 4). The electron microscopic images of represen-
tative individual RSD particles are to be seen in Fig. 5. The particles
were generally irregularly shaped with a coarse surface that might
facilitate the adhesion of these particles on the airway epithelium.
Fig. 6 illustrates the baseline values of the airway and respira-
tory tissue mechanical parameters for the rats in both groups. RSD
exposure did not lead to any signiﬁcant change in Raw (p = 0.65) or
 (p = 0.90). There was a tendency for G and H to increase in the
rats exposed to RSD, but these differences did not reach the level
of statistical signiﬁcance (p = 0.071 and p = 0.10, respectively).




















Fig. 4. Chemical compositions of 5 samples of RSD aggregates.
116 D. Czövek et al. / Toxicology Letters 209 (2012) 113– 120
Fig. 5. Electron microscopic images demonstrating the topology of 4 representative RSD aggregates.
The changes in the airway and tissue parameters in the con-
trol and RSD-exposed animals following the MCh  challenges are
demonstrated in Fig. 7. MCh  caused marked dose-dependent
increases in Raw, G and  (p < 0.001), while the increases in H were
less pronounced, but still statistically highly signiﬁcant (p < 0.001).
The signiﬁcant interactions revealed between MCh  and RSD by two-
way ANOVA (p = 0.005) indicated that RSD inhalation affected the
magnitude of the MCh-induced increases in Raw, i.e. AH developed
in the RSD group. The presence of AH following RSD inhalation was
also reﬂected in the signiﬁcantly lower ED100 values in the RSD
group than in controls (5.3 ± 0.2 vs. 7.5 ± 0.9 g/kg, respectively,
p = 0.041).
Representative histological sections in lungs obtained from rats
in both groups are demonstrated in Fig. 8. Inhalation of RSD led to
perivascular inﬁltration (in decreasing sequence of particle amount
in lymphocytes, plasma cells, eosinophils, mastocytes and neu-
trophils) and perialveolar inﬁltration (in decreasing sequence in







































































Fig. 6. Baseline (BL) values of airway resistance (Raw), respiratory tissue damping (G) and elastance (H), and hysteresivity () in individual rats (circles). Horizontal lines
denote  the group means.
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Fig. 7. Airway and respiratory tissue parameters measured after MCh  challenges
relative to the baseline (BL) values in the control rats (closed circles) and in rats
exposed to RSD (open circles). Horizontal lines denote the group mean values. *:
p  < 0.05 vs. the baseline; #: p < 0.05 between the groups.
In the alveolar areas which exhibited an inﬂammatory response,
RSD particles were recovered as ﬁne, granular and pigmented cyto-
plasmatic inclusions in the alveolar macrophages.
Fig. 9 depicts the histological ﬁndings. Prolonged exposure to
RSD induced the development of mild hyperemia (p = 0.03) and
the mild-to-moderate inﬁltration of inﬂammatory cells into the
perivascular (p = 0.003) or perialveolar (p < 0.001) areas. No differ-
ence in BALT hyperplasia was observed between the two  groups
(p = 0.43).
4. Discussion
The present study examined the respiratory consequences of
prolonged inhalation of RSD extracted from on-site sampling
of toxic red sludge following the environmental disaster near
Ajka (western Hungary). The exposure of rats to RSD in high
concentrations caused no detectable changes in the basal airway
and respiratory tissue parameters, whereas this irritation led to
the development of mild AH. Histological investigations revealed
that this adverse respiratory consequence of the RSD was associ-
ated with a mild-to-moderate inﬂammatory response around the
pulmonary blood vessels and in the alveolar walls.
4.1. Physical properties and chemical composition of the RSD
exposure model
Since the exposure of the rats to RSD was performed under lab-
oratory conditions following drying and mechanical grinding of an
authorized red sludge sample collected at the site of the disaster,
the relationship of the concentration, the physical properties and
the chemical composition of our RSD powder to the on-site ﬁeld
samples of the ambient particles warrant consideration.
As concerns the concentration of the RSD particles in the
exposure chamber, the mass of airborne particles varied cycli-
cally between 1 and 7 mg/m3 (Fig. 2). This pattern, mimicking
wind gusts in the area affected by the disaster, resulted in a
mean ﬂoating mass concentration of RSD (3.3 mg/m3) that was
about two orders of magnitude greater than the levels observed
around the devastated area in the months following the acci-
dent (http://www.kvvm.hu/olm/index.php,  2011. Ministry of Rural
Development, Hungary). Considering the limited time available for
the exposures of the animals, we  deliberately made the concentra-
tion high enough for mild-to-moderate respiratory symptoms to
appear, and to achieve a total RSD dose exposure similar to what
might be expected for the people living continuously in the affected
areas for a period of some years.
Since the particle size fundamentally affects its deposition in the
respiratory system, another important aspect of our experiments
was the size distribution airborne particles. The critical diameter
for particles to reach the lower respiratory tract by inhalation in
humans is about 10 m (Oberdorster, 2001; Salma et al., 2001).
Since almost all of the RSD particles in our investigation were
smaller than this limit, this exposure was  appropriate for study
of the respiratory consequences of RSD inhalation (Fig. 3). This was
evidenced by the lung histology, which revealed particles as cyto-
plasmatic inclusions in the alveolar macrophages (Fig. 8). The size
distribution obtained in the present study differs from data pub-
lished earlier on resuspended red dust samples (Gelencser et al.,
2011), where somewhat greater particles were detected. This dif-
ference could be explained by methodological differences in RSD
preparation, since the resuspended red sludge samples in that pre-
vious ﬁeld study were collected from agricultural soil and contained
larger particles less likely to become airborne. We  exposed rats
to particles made airborne by applying a positive pressure airﬂow
stream to previously dried powder in a chamber. In order to verify
our results, we made independent in situ measurements on air-
borne material with the same instrumentation at Devecser, where
we likewise detected a negligible amount of particles with diam-
eters >500 nm.  Our applied approach, therefore, appears to give a
better simulation to the situation when the wet red sludge is dried
by the sun and the resulting ﬁne dry dust particles are blown by
wind gusts into the air, reaching heights relevant to the exposure
of humans to inhalable dust (∼2 m).
The topology and composition of the RSD used in the present
exposures agreed well with those obtained previously by analyzing
on-site ﬁeld samples (Gelencser et al., 2011). Topological examina-
tion conﬁrmed that the RSD particles had irregular shapes with a
coarse surface (Fig. 5), which is likely to promote the adhesion of
such particles on the lower respiratory tract. The main components
were the elements present in the bauxite and remaining following
the Bayer process (e.g. Fe, Ti and Mg), while other less frequent
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Fig. 8. Histological sections obtained in a representative control rat (A, left) and in another rat exposed to RSD (B, right) at a magniﬁcation of 10×.  A/1 and B/1 are magniﬁcation
of  a pulmonary vessel, while A/2 and B/2 focus on alveolar regions (magniﬁcation 20×). B/3 depicts ﬁne granular and pigmented cytoplasmatic inclusions of RSD particles in
macrophages.
components (e.g. Si and Ca) originated from the soil soaked by the
red sludge (Fig. 4).
4.2. Effects of RSD on basal lung function
Despite the high RSD concentration and the evidence that
it accessed the lower respiratory tract, no clinically signiﬁcant
adverse changes in the baseline airway or respiratory tissue
mechanics were detected in the present study (Fig. 6). The ten-
dency to higher G and H in the animals in the RSD group may  be a
consequence of the mild inﬂammation demonstrated by the lung
histology (Fig. 9). The development of airway inﬂammation agrees
with previous ﬁndings on animals exposed to high concentrations
of inhalable particles originating from carbon black (Lambert et al.,
2003; Li et al., 1996), ultraﬁne TiO2 (Oberdorster, 2001), urban air
pollution (Dong et al., 2005; Harkema et al., 2004), and ﬁne particu-
late matter arising from the destruction of the World Trade Center
(Gavett et al., 2003). Since merely mild airway inﬂammation has no
major effects on the basal lung function (Dong et al., 2005; Novak
et al., 2006; Petak et al., 2010; Stevens et al., 2009), the lack of dif-
ference between the two  groups is consistent with the previous
results.
4.3. Airway inﬂammation and responsiveness following RSD
inhalation
In agreement with previous ﬁndings that inhaled particulate
matter induced asthma-like symptoms (Dong et al., 2005; Kilburn,
1984; Lambert et al., 2003; Maatta et al., 2006; Nel et al., 2001;
Stevens et al., 2009; Wang et al., 2008), the airway inﬂammation
that occurred following RSD inhalation in the present study led
to the development of AH, which was manifested in signiﬁcantly
elevated responses to MCh  (Fig. 7) and subsequent decreases in
ED100. As concerns the mechanism of the emergence of AH, the
involvement of macrophages can be anticipated from the histo-
logical ﬁndings (Fig. 8), since the role of alveolar macrophages in
the development of an inﬂammation response in the small air-
ways was  evidenced previously (Maatta et al., 2006; Oberdorster
et al., 1992). Acute inﬂammation is probably caused by the phago-
cytosis of inhaled particles by alveolar macrophages and the
release of inﬂammatory mediators from these cells. This injury
response already appears within a few hours after inhalation and
is particle size-dependent: the most destructive particles are the
ultraﬁne ones (<50 nm), which are able to pass into the phagocytes
(Mantecca et al., 2010). Since a substantial proportion of the par-
ticles in our study were in this size range, the involvement of this
mechanism is expected. Chronic dust inhalation drives the inﬂux
of macrophages and other inﬂammatory cells, and these factors
may  lead to the progress of chronic lung diseases such as asthma
(Andersen et al., 2008; Dong et al., 2005), emphysema, bronchiolitis
(Girod and King, 2005) or ﬁbrosis (Oberdorster et al., 1992).
4.4. Limitations
The present study investigated the short-term pulmonary con-
sequences of exposure to a high dose of RSD in healthy adult rats,
an adequate model of long-term RSD inhalation in adult individ-
uals with normal lungs. However, it must be borne in mind that
susceptibility of the lungs to exogenous stimuli may  be enhanced
by many factors, such as a persistent lung disease (Harkema et al.,
2004; Lambert et al., 2003; Martins et al., 2011), respiratory infec-
tion (Zanobetti et al., 2000) and age, with an increased risk of
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Fig. 9. Numbers of control (closed bars) and RSD-treated rats (open bars) with different severity scores based on the histopathological evaluations.
pulmonary complications in response to particulate air pollution
in both the pediatric (Martins et al., 2011) and the elderly (Laskin
et al., 2010) population. The detrimental effects of RSD exposure
on the pulmonary system may  therefore be exaggerated when
such factors are present, they must form the subject of further
investigations. Another important feature in the present study is
the limited time allowed for the potential manifestation of pul-
monary diseases. While the development of inﬂammation was
demonstrated by the histopathological results, its potential long-
term consequences were not been covered. Previous studies have
indicated that the inhalation of various dust particles may  involve
long-term adverse pulmonary effects that may  promote the devel-
opment of COPD (Girod and King, 2005), sarcoid-like pulmonary
disease (Izbicki et al., 2007) and diffuse parenchymal lung disease
(Szeinuk et al., 2008); accordingly, these slowly progressing lung
diseases demand further studies with longer time-frames.
5. Conclusions
Fine airborne particles of the dried red sludge following an envi-
ronmental disaster near Ajka in 2010 and around regions near dry
storage reservoirs have given rise to serious public health concerns,
with a particular fear of respiratory complications. We  examined
the effects of RSD produced from an on-site sample in the Ajka
region on the pulmonary system by performing basal lung function
measurements, with the assessment of changes in lung responsive-
ness and also histopathological analyses. When rats were exposed
to a high concentration of RSD, the ﬁne powder particles reached
the lower respiratory tract, but the alterations in the basal air-
way and respiratory tissue mechanics were not signiﬁcant. The
mild inﬂammation that developed around the pulmonary vessels
and in the alveolar wall was  associated with a mild bronchial
hyper-reactivity. Since these mild respiratory symptoms emerged
following exposure to extremely high concentrations, our results
may  suggest that the short-term health hazard as regards the pul-
monary system in healthy human adults exposed to RSD inhalation
is not greater than that due to urban dust at a comparable concen-
tration.
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Spirometry and Forced Oscillations in the Detection of
Airway Hyperreactivity in Asthmatic Children
Ferenc Peta´k, PhD,1* Dorottya Czo¨vek, MD,2 and Zolta´n Nova´k, MD, PhD2
Summary. Background: Provocation tests are routinely used to detect airway hyperreactivity
(AH) in the diagnosis of asthma. We compared the sensitivities of the forced oscillation tech-
nique (FOT) and spirometry in the detection of AH in asthmatic children. Methods: FOT and
spirometry were performed in 20 asthmatic children (aged 5–18 years) following aerosolized
histamine and methacholine at an interval of 2 weeks. The respiratory system input impedance
was measured by FOT; the resistance at 6 Hz (R6), the average resistance between 4 and
24 Hz, the area under the reactance curve (AX) and the resonant frequency were extracted
from these recordings. Spirometry was used to obtain forced expiratory volumes and ﬂow
parameters. Results: Following provocation with the two agonists, the FOT detected the airway
response as early as spirometry. When the greater variability of the impedance parameters
was taken into account, the two methods were observed to have similar sensitivities. Among
the lung function parameters studied, AX and R6 were the most sensitive for the demonstration
of AH. Conclusions: Our ﬁndings demonstrate that FOT is as suitable as spirometry for the
measurement of bronchoconstriction and thus it may be considered for the detection of AH in
asthmatic children. Since its application requires minimal cooperation, this approach imposes
less stress and may be particularly favorable in the diagnosis of asthma at a young age.
Pediatr Pulmonol. 2012; 47:956–965.  2012 Wiley Periodicals, Inc.
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INTRODUCTION
The airway hyperreactivity (AH) during bronchopro-
vocation tests plays a key role in the diagnosis of asth-
ma.1–4 The early diagnosis and adequate treatment of
asthma in early childhood signiﬁcantly improve the
prognosis and the quality of life.5 In older children or
adults, the AH can be detected indirectly by performing
spirometry during airway challenges with an inhaled
bronchoconstrictor agonist. However, the measurement
of lung function and the subsequent detection of AH in
young children are limited by their inability to perform
the close cooperation necessary for spirometry.
The forced oscillation technique (FOT) has gained
increasing attention for the measurement of pulmonary
mechanics in children because this approach requires
no special breathing maneuvers.6,7 Moreover, in con-
trast with spirometry, the FOT provides direct informa-
tion on the mechanical properties of the airways and
the respiratory tissues. These beneﬁcial properties of
the FOT have resulted in numerous previous studies in
which the lung function was assessed in children with
no respiratory disease,8–10 or with various lung diseases
such as cystic ﬁbrosis,9,11–14 neonatal chronic lung dis-
ease,9,15 wheezy bronchitis,9,16–18 or asthma.1–3,9,10
Despite the potential of the FOT to detect early bron-
choconstriction during different challenges, the sensitiv-
ity of this method has not been systematically evaluated
with the gold standard of spirometry in asthmatic
children. The aims of the present study were therefore
(i) to compare the sensitivities of the FOT and spirome-
try during airway challenges involving the inhalation of
different direct stimuli commonly used in clinical prac-
tice (histamine [His] and methacholine [MCh]) and
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(ii) to establish which FOT parameter and which provo-




Twenty asthmatic children (5 girls and 15 boys, age
range 5–18 years) were enrolled into the study. The di-
agnosis of asthma, the degree of its severity, and the
level of control were categorized according to the
GINA (Global Initiative for Asthma) guidelines,19
based on the previous history of recurrent coughing,
wheezing, shortness of breath (at rest or following exer-
cise), and the symptomatic improvement following
short-acting bronchodilator administration. Each child
and/or their guardian completed the informed consent
document, which was approved by the Clinical Ethics
Committee of the University of Szeged (Ref No.
WHO2803). Seventeen children did not receive any reg-
ular asthma medication during one month prior to the
study; they used only inhaled salbutamol (Sal) occa-
sionally, as needed (GINA level 1). Three children used
inhaled corticosteroid (ICS) as maintenance (budeso-
nide 200 mg twice a day) and Sal (200 mg as needed)
as rescue therapy (GINA level 2). All children were
controlled during the study period. Only patients
who did not need Sal during 8 hr before the visit were
included in the study.
Forced Oscillations
The FOT measurements were performed in accor-
dance with the ERS guidelines.6 To measure the input
impedance of the respiratory system (Zrs) during spon-
taneous breathing, a commercially available device
(i2m, Chess Medica, Oostakker, Belgium) was applied.
Brieﬂy, a loudspeaker was used to generate the pseudo-
random broad-band oscillatory pressure signals contain-
ing integer multiple frequencies between 4 and 48 Hz.
The forcing signal was applied to the child via a dispos-
able bacterial ﬁlter and a mouthpiece (Type PBF-30,
Piston Ltd., Budapest, Hungary). Zrs was obtained from
8-sec measurements while the child performed normal
breathing during the oscillatory measurements. The
equipment was calibrated by measuring known impe-
dances prior to the measurements. The additional
impedance of the bacterial ﬁlter and mouthpiece was
determined and the Zrs spectra were corrected for this
equipment component.
During the 8-sec data recording periods, the children
sat upright, wearing a noseclip, and breathing quietly
through the mouthpiece. They were asked to support
their cheeks with their palms during these maneuvers in
order to minimize upper airway shunting. The Zrs
recordings were accepted if the coherence functions
between the pressure and ﬂow signals were generally
>0.95, no leak was noted around the mouthpiece, and
no technical artifact occurred due to coughing, swal-
lowing or glottis closure.
The changes in the resistive properties of the respira-
tory system were evaluated by calculating the average
resistance between 4 and 24 Hz (R4–24) and by extract-
ing the resistance and reactance at 6 Hz (R6 and X6; the
lowest frequency at which the impedance was reliably
measured). The elasticity of the respiratory system was
assessed by calculating the sum of all negative values
in the imaginary part of Zrs from 4 Hz, which corre-
sponds to the area above the reactance curve and the
x-axis (AX). The resonance frequency of the respiratory
system (Fres), that is, the frequency at which the reac-
tance was zero, was determined by linear interpolation.
Spirometry
Spirometry was performed in accordance with the
ATS/ERS recommendations.20 Forced expiratory ﬂow-
volume curves were measured by means of a commer-
cial spirometer (Type PDD-301/s, Piston Ltd., Buda-
pest, Hungary) including a screen pneumotachograph
equipped with a differential pressure transducer. The
ﬂow signal was integrated to obtain changes in lung
volume during the forced expiratory maneuvers. The
forced expiratory volume in the ﬁrst second of expira-
tion (FEV1), the forced vital capacity (FVC), and the
forced expired ﬂow between 25% and 75% of the vol-
ume expired (FEF25–75) were extracted from the record-
ings. Three technically acceptable reproducible
measurements were performed, and the highest values
of the spirometric parameters were extracted from the
maneuvers for the ﬁnal analyses.
Measurement Protocol and Bronchial Challenges
On the ﬁrst study day, three-to-ﬁve reproducible Zrs
data epochs were recorded, which were followed by
three consecutive technically acceptable forced expira-
tory maneuvers in order to establish the baseline values
of the FOT and spirometric lung functional parameters.
Since the FOT does not require any special breathing
maneuvers, this technique was always performed ﬁrst.
The deep inspirations and forced expirations necessary
for spirometry may affect FOT measurements.13,21 This
sequence guaranteed the lack of inﬂuence of the assess-
ments themselves on the measured values. Increasing
doses of aerosolized (Voyage Mefar jet nebulizer, Italy)
His (Sigma–Aldrich Ltd., Budapest, Hungary) was then
administered (airﬂow 8 L/min, mass median aerody-
namic diameter 1.9 mm, minimum output 0.3 ml/min)
to the children for 2 min via a face mask, in doubling
doses ranging from 0.5 to 16 mg/ml. A set of Zrs
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recordings was ﬁrst collected, including measurements
of three 8-sec data epochs at 10, 50, and 90 sec after
the end of the inhalation. This was followed by three
forced expiratory maneuvers for spirometry at 2, 2.5,
and 3 min after the completion of each dose. An inter-
val of at least 5 min was allowed between two consecu-
tive doses. The study was terminated before the highest
dose of His, or if FEV1 decreased by more than 20%
and/or clinical symptoms of wheeze or persistent cough
were noted.22,23 To detect the reversibility of the bron-
choconstriction, the challenge protocol was terminated
in all children by administering 400 mg inhaled Sal
(Ventolin, GlaxoSmithKline, Greenford, UK) followed
by the ﬁnal assessment of Zrs and spirometry.
The children revisited the lung function laboratory
2 weeks later. The baseline FOT and spirometry were
performed identically as detailed above. Aerosolized sa-
line as the solvent of the agonists was then adminis-
tered for 2 min, and both the FOT and spirometry were
repeated. The bronchoprovocation tests with increasing
doses of MCh (0.5–8 mg/ml for 2 min) and the bron-
cholysis with Sal were then repeated in the same man-
ner as detailed above.
The deep inspirations and forced expirations neces-
sary for spirometry may affect FOT measurements.13,21
Accordingly, to test whether the variability of the FOT
parameters was altered when this lung function test was
performed alone, another 8 asthmatic children similar
to the main study population were studied (three girls
and ﬁve boys, age range 6–16 years, weight range
27–74 kg, height range 122–164 cm). Two sets of Zrs
recordings by the FOT were collected in these children
at times 5 min apart.
Statistical Analyses
Short-term variability in the spirometric and FOT
parameters was deﬁned as the standard deviation of per-
centage changes between measurements before and af-
ter NaCl inhalations, while long-term variability was
determined by calculating the standard deviation of per-
centage changes between the two baseline values at the
two visits. The Z score for each parameter was calculat-
ed as the difference between the post-test and the basal
value divided by the standard deviation of the expected
value of the change (i.e., the short-term variability).
This Z score is the number of standard deviations by
which a lung function parameter responded to the con-
strictor agonists as compared with inhalation of the sol-
vent. Responses were considered statistically signiﬁcant
when the Z scores for each parameter were outside the
1.96 and þ1.96 critical levels. The Z-test comparing
two proportions was applied to detect statistical signiﬁ-
cance between the lung function parameters. To express
group means and deviations, the values are reported as
means  SE. The Kolmogorov–Smirnov test was used
to test data for normality. The changes in the group
means of the FOT and spirometric Z score parameters
were assessed by using one-way ANOVA tests on re-
peated measures. The relationships between the contin-
uous variables (i.e., the FOT and spirometry indices)
were examined by means of Pearson correlation tests.
Pairwise comparisons were performed by using the
Student–Newman–Keuls multiple comparison proce-
dures. Statistical signiﬁcance was accepted at the level
P < 0.05.
RESULTS
The children had normal basal lung function param-
eters, with a mean percentage predicted value for FEV1
of 106% (range 93–136%) and a mean Z score of 0.54
(ranging between 1.0 and þ1.43). The mean FVC
was 105% (67–121%), with a Z score of 0.48 (ranging
between 1.3 and þ1.75). FEF25–75 was also normal,
with a mean percentage predicted value of 106% (77–
124%) and a mean Z score of 0.62 (ranging between
2.05 and þ3.04).24 The mean respiratory resistance
between 4 and 24 Hz (R4–24) was 91% of the percent-
age predicted (range 74–105%).
Data on the short- and long-term variabilities in the
spirometric and FOT parameters are demonstrated in
Table 1. The smallest variabilities were found for FEV1
and FVC, those for FEF25–75, R4–24 R6 were higher, and
the highest were observed for X6 AX and Fr in the chil-
dren who participated in both the FOT and spirometry.
Substantial decreases in the short-term variability were
observed for the FOT parameters in the eight additional
TABLE 1—Percentages of Short- and Long-Term
Variability of the Lung Function Parameters Determined
With Spirometry or Forced Oscillations in the Main Study











R4–24 10.3 (6.1) 13.8
R6 11.3 (6.2) 12.2
X6 15.41 (7.2) 18.7
AX 25.6 (17.0) 31.9
Fr 16.7 (9.2) 25.7
Values in parentheses: values obtained in eight additional children
where the FOT was performed without spirometry (three girls and
ﬁve boys, age range 6–16 years). Variability was deﬁned as the stan-
dard deviation of the percentage changes between the data obtained
in the ﬁrst and second tests.
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children where the FOT data were collected without
spirometry.
Figure 1 illustrates the Z scores for the spirometric
and FOT parameters during the MCh challenge proto-
col. Inhalation of saline following the baseline record-
ings did not cause signiﬁcant changes in any of the
lung function parameters (P ¼ 0.47, 0.34, 0.75, 0.98,
0.84, 0.78, 0.94, and 0.55 for FEV1, FEF25–75,
FVC, R4–24, R6, X6, AX, and Fr, respectively). Inhala-
tion of increasing doses of MCh resulted in dose-depen-
dent decreases in FEV1, FEF25–75 (P < 0.001 for both)
and FVC (P ¼ 0.002). All parameters obtained with the
FOT displayed dose-dependent signiﬁcant increases fol-
lowing MCh inhalation (P < 0.001 for all). Inhalation
of Sal after these bronchial provocations totally abol-
ished the bronchoconstrictor effects of MCh. Similar to
His, the resistance parameters obtained by FOT were
able to detect signiﬁcant decreases in the airway tone
after Sal inhalations (P ¼ 0.002 for R4–24, P ¼ 0.006
for R6), while these changes were not reﬂected in the
spirometric indices. Statistical results on these ﬁndings
are presented in Table 2. The ﬁnal concentration of
MCh caused signiﬁcant changes in the spirometric and
forced oscillatory indices in the majority of the chil-
dren; Z-tests revealed no signiﬁcant difference between
forced expiratory ﬂow parameters (FEV1 and FEF25–75)
and lung function indices obtained by forced
oscillations.
The Z scores of the spirometric and FOT parameters
during His challenges are depicted in Figure 2. Increas-
ing doses of aerosolized His caused statistically signiﬁ-
cant decreases in the lung volume/ﬂow indices
determined by spirometry (P < 0.001 for FEV1 and
FEF25–75; P ¼ 0.011 for FVC). The parameters extracted
from the real and imaginary parts of the Zrs spectra
exhibited dose-dependent elevations after His provoca-
tion (P < 0.001 for R4–24, R6 and Fr, P ¼ 0.005 for X6
and AX). The lung function parameters obtained with
spirometry after Sal inhalation were not signiﬁcantly dif-
ferent from those measured at the beginning of the study,
but administration of Sal led to signiﬁcant decreases
in R6 (P < 0.005), X6 (P < 0.005), and AX (P < 0.05),
indicating that the decreases in the airway tone by the b2
agonist may be reﬂected in the FOT indices. Table 3
containes the results of the Z-test on the data in Figure 2.
The majority of the children responded to His at the ﬁnal
concentration; Z-tests revealed no signiﬁcant difference
between the forced expiratory ﬂow parameters (FEV1
and FEF25–75) and the resistance parameters obtained by
forced oscillations.
Fig. 1. The Z scores of the lung function parameters obtained
with spirometry (left) or forced oscillations (right) in individual
asthmatic children under the baseline condition (BL), follow-
ing inhalations of normal saline (NaCl) and increasing doses
of methacholine (0.5–8.0 mg/ml), and after inhalation of salbu-
tamol (SA). Horizontal dashed lines indicate the limits of statis-
tical signiﬁcance (Z score 1.96).
TABLE 2—P Values Resulting From the Z-Tests Comparing Two Proportions for the Lung Function Parameters Obtained
With Spirometry and Forced Oscillations During the Methacholine Challenges
R4–24 (13/7) R6 (17/3) X6 (16/4) AX (16/4) Fr (13/7)
FEV1 (14/6) 0.73 0.26 0.46 0.46 0.73
FEF25–75 (14/6) 0.73 0.26 0.46 0.46 0.73
FVC (8/12) 0.11 0.003 0.01 0.01 0.11
Values in parentheses: number of children with signiﬁcant change to the highest dose of histamine (deﬁned as the Z score for each parameter
exceeding the critical levels of 1.96 or þ1.96) over the number of children with no signiﬁcant change.
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To compare the sensitivities of spirometry and the
FOT in the detection of airway narrowing, the absolute
values of the Z scores for the lung function parameters
during the His and MCh challenges (determined with
spirometry and the FOT) are presented in Figure 3.
Data are shown for the lower part of the dose-response
curve, where measurements were made for the majority
of the children (i.e., prior to a 20% decrease in FEV1 or
the appearance of clinical symptoms). The sensitivities
of the FOT parameters related to the low-frequency part
of the Zrs spectra were among the greatest during both
His and MCh challenges. R6 and FEF25–75 exhibited
similarly high sensitivities in the detection of His- or
MCh-induced airway narrowing. The parameters X6,
AX, Fr, FEV1, or FEF25–75 were also able to detect
bronchoconstriction after His and MCh challenges, but
only after the second doses of the constrictor agonists.
Since the variability in the FOT parameters was
greater than that in the spirometric indices, we exam-
ined the magnitude of the changes in the resistance
parameters where the His and MCh provocation tests
became positive according to the ATS/ERS guidelines
(a 20% decrease in FEV1 or the appearance of clinical
symptoms). These data are displayed in Table 4. When
a positive response was detected during the bronchial
challenge tests, the changes in R4–24 were about twice
as high as those in the FEV1 for both of the constrictor
agonists studied, while the elevations in R6 were even
more pronounced.
The FEV1 values obtained with spirometry and
the resistance values in the medium frequency range
Fig. 2. The Z scores of the lung function parameters obtained
with spirometry (left) or forced oscillations (right) in individual
asthmatic children under the baseline condition (BL), follow-
ing inhalations of increasing doses of histamine (0.5–16 mg/
ml) and after inhalation of salbutamol (SA). Horizontal dashed
lines indicate the limits of statistical signiﬁcance (Z score
1.96).
TABLE 3—P Values Resulting From the Z-Tests Comparing Two Proportions for the Lung Function Parameters Obtained
With Spirometry and Forced Oscillations During the Histamine Challenges
R4–24 (17/3) R6 (18/2) X6 (14/6) AX (13/7) Fr (12/8)
FEV1 (18/2) 0.63 1 0.42 0.058 0.028
FEF25–75 (16/4) 0.67 0.38 0.32 0.29 0.17
FVC (8/12) 0.003 0.001 0.09 0.11 0.21
Values in parentheses: number of children with signiﬁcant change to the highest dose of histamine (deﬁned as the Z scores for each parameter
exceeding the critical levels of 1.96 or þ1.96) over the number of children with no signiﬁcant change.
Fig. 3. The absolute Z scores for the lung function parameters
obtained with spirometry (ﬁlled symbols) and forced oscilla-
tions (open symbols) following histamine or methacholine
challenges. P < 0.05 versus FEV1 within a dose, #P < 0.05
versus zero level within a parameter.
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(4–24 Hz) obtained with the FOT are primarily deter-
mined by the geometry and the mechanical properties
of the central conducting airways. Conversely, the con-
tributions of the small airways appear in the spirometric
FEF25–75 and the low-frequency resistance values, such
as R6.
7,25 Accordingly, we characterize the associations
between these corresponding spirometric and FOT indi-
ces during the His and MCh challenges in Figure 4.
During His challenges, strong and statistically signiﬁ-
cant correlations were observed between FEV1 and
R4–24 (R
2 ¼ 0.6, P < 0.0001) and between FEF25–75
and R6 (R
2 ¼ 0.47, P < 0.0001). The correlations be-
tween these parameters during MCh challenges were
somewhat weaker but their associations were still close
and highly signiﬁcant (R2 ¼ 0.48, P ¼ 0.0001 between
FEV1 and R4–24 and R
2 ¼ 0.5, P < 0.0001 between
FEF25–75 and R6).
DISCUSSION
The results of the present study demonstrated con-
comitant changes in the lung function parameters deter-
mined with spirometry and the FOT during different
bronchial challenges in asthmatic children, with signiﬁ-
cant correlations between the corresponding parameters.
Inhalation of increasing doses of His or MCh caused
bronchoconstriction, which was detected similarly from
both the spirometric and the FOT parameters. Express-
ing the changes in Z scores, which take into account the
different variabilities in the lung function parameters,
revealed that the sensitivities of the lung function indi-
ces are comparable in spirometry and the FOT for the
detection of bronchoconstriction induced by His and
MCh in asthmatic children.
Since the introduction of the FOT by Dubois in
195626 and its extension toward the application of a
wide frequency range of pseudorandom pressure excita-
tion,27 the popularity of this lung mechanical measure-
ment technique has increased, particularly as concerns
examinations of patients with a limited ability to coop-
erate.1–3,7–9,11–15,17,18,28–30 This beneﬁcial proﬁle of the
FOT allows the characterization of lung function abnor-
malities in children with various respiratory diseases,
such as cystic ﬁbrosis,9,11–14 neonatal chronic lung dis-
ease,9,15 wheezy bronchitis,9,16–18 or asthma.1–3,9,10 Fur-
thermore, the FOT has been used successfully to
characterize bronchodilator responsiveness9,18,28 and to
detect lung function changes following the inhalation of
a bronchoconstrictor agonist in children.2,3,16,17 How-
ever, we are aware of only a few previous studies in
which the sensitivities of the FOT and spirometry were
compared with regard to the detection of AH in asth-
matic children,1,29,30 when the bronchial challenges are
performed in accordance with the ATS guidelines.23 In
TABLE 4—Percentage Changes in the Resistance Parameters Where the Histamine and Methacholine Provocation Tests
Became Positive According to the ATS/ERS Guidelines (a 20% Decrease in FEV1 or the Appearance of Clinical
Symptoms)
Histamine Methacholine
R4–24 R6 Response R4–24 R6 Response
1 38.1 59.4 W 82.0 172.8 W
2 48.4 80.9 SW 80.9 77.6 SW
3 53.6 124.1 W 56.9 110.4 SW
4 16.1 24.9 SW 38.7 80.1 SW
5 37.0 53.4 SW 39.7 51.6 SW
6 41.5 1.5 W 30.8 38.8 W
7 64.9 107.8 SW 53.6 76.1 SW
8 46.8 48.3 SW 28.9 36.8 SW
9 66.9 116.8 SW 7.1 20.0 SW
10 25.8 46.7 SW 5.2 17.3 W
11 12.3 27.3 SW 5.3 5.94 SW
12 20.7 40.4 W 40.8 54.4 W
13 5.9 5.5 SW 2.7 19.8 SW
14 16.3 31.0 SW 30.8 62.4 SW
15 27.7 23.6 W 2.9 11.3 W
16 34.8 11.1 SW 24.1 41.0 SW
17 38.6 58.0 SW 11.4 8.1 SW
18 23.4 23.1 W 12.8 9.9 SW
19 7.0 23.2 SW 10.7 28.3 SW
20 15.5 40.9 W 46.9 43.4 SW
Mean 32.1 48.9 27.6 49.7
SE 4.1 8.7 5.4 10.1
SW, positive response (20% decrease in FEV1 and the appearance of wheeze); W, wheeze, clinical symptoms appeared.
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agreement with the present ﬁndings (Fig. 4), signiﬁcant
correlations between forced expiratory and impedance
parameters were found in these previous reports follow-
ing inhalation of His30 or MCh.29 The sensitivity of the
resistance and reactance parameters of the respiratory
impedance spectra for the detection of bronchoconstric-
tion in asthmatic children following MCh inhalation
also accords with previous ﬁndings.1 These earlier stud-
ies lack a comprehensive analysis of the sensitivities of
the lung function parameters involving a consideration
of the differences in variability of the techniques ap-
plied. Since spirometry is a routine procedure in lung
function laboratories for the detection of AH in the di-
agnosis of asthma, demonstration of the similar ability
of the FOT is of major importance, since this technique
can be carried out reliably in a much younger age group
(as low as 2 years of age3,10). Nevertheless, children of
school age were enrolled in the present study, in order
to allow a comparison with spirometry. The diagnosis
of asthma via the detection of AH would require the
involvement of an age-matched healthy control group.
This would have required the enrolment of healthy chil-
dren in a similar age range for the two bronchoprovoca-
tion tests with His and MCh, but this was not feasible
at our institution. Despite our having the limitation the
lack of a healthy control group, however, the compari-
sons of the changes in the FOT with the spirometric
indices during bronchoprovocation tests still provides
Fig. 4. Correlations observed between spirometric and resistance parameters obtained with
forced oscillations following aerosolized histamine (top) or methacholine (bottom) challenges
in individual asthmatic children.
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valuable information concerning the ability of the for-
mer approach to detect airway narrowing. This similar
ability suggests that AH can be detected reliably in
asthmatic children by using the FOT.
Strong and highly signiﬁcant correlations were ob-
served between the corresponding FOT and spirometric
parameters relating to the larger (FEV1 vs. R4–24) and
smaller airways (FEF25–75 vs. R6), which suggests that
airway narrowing is faithfully reﬂected by both techni-
ques. Nevertheless, the correlation analysis does not
take into account the variability of the measured param-
eters, which is of great importance in a comparison of
the ability of a lung function test to measure broncho-
constriction with subsequent promise to detect AH. Pre-
vious studies have established that lung function
parameters obtained by measurement techniques uti-
lized during tidal breathing exhibit somewhat greater
variability than those based on forced expiration.11 In
accordance with that ﬁnding, we experienced greater
short- and long-term variabilities for the FOT param-
eters than those measured with spirometry. This implies
that greater magnitudes of changes can be regarded as
positive responses in the FOT parameters (Table 4),
which corresponds to previous observations2,17,22 and
recommendations for higher acceptance limits of clini-
cally important changes.22
In order to take the greater magnitudes of the
changes and the somewhat higher short-term variability
in the FOT parameters into account, the alterations in
the lung function indices during the His and MCh chal-
lenges were also expressed in Z scores. This analysis
revealed comparable Z scores for the lung function
parameters determined with the FOT and spirometry in
the detection of airway narrowing during both the His
and the MCh challenges. However, in agreement with
previous ﬁndings,1 there was a tendency to a greater
sensitivity of the FOT parameters relating to the low-
frequency part of the Zrs spectra, which was particular-
ly evident for R6. It is also noteworthy that the reac-
tance parameter X6 and AX reﬂected the lung function
changes after both His and MCh inhalation. Since these
parameters are extracted from the low-frequency reac-
tance, they primarily reﬂect changes in the elasticity of
the total respiratory system. It, therefore, seems likely
that, besides inducing a constriction of the conducting
airways manifested in elevated forced expiratory lung
volumes and resistance parameters, the inhalation of the
bronchoconstrictor agonists also led to a stiffening of
the respiratory tissues. The most probable mechanism
responsible for such a change in the respiratory elastici-
ty is the loss of lung volume via the development of air
trapping, due to the uneven deposition of the broncho-
provocation agonists, which was earlier clearly demon-
strated during challenges with aerosolized His.21,31 The
lack of a signiﬁcant decrease in FVC despite this loss
of lung volume may be related to the forced deep inspi-
ration to the total lung capacity prior to the expiration,
which has been shown to be likely to reopen the com-
promised lung regions.21
As concerns the greater variabilities in the parameters
determined with the FOT than those with spirometry,
the sequence of the tests in the present experimental
setting warrants consideration. Since the FOT requires
normal quiet breathing only, it has no inﬂuence on the
spirometric outcome. This sequence of the tests ensured
the minimal interaction between the two lung function
tests. Nevertheless, the deep inspiration and subsequent
forced expiration maneuvers necessary for spirometry
may affect the lung mechanics, which may be mani-
fested even 5 min later in the FOT recordings. In addi-
tion to the potential diminution of the lung functional
changes that results from the deep inspirations homoge-
nizing the lung periphery,21 these forced breathing
maneuvers may also widen the short-term variability of
the FOT parameters obtained in the present study,
which then ultimately affect the Z scores extracted from
the Zrs spectra, and hence the sensitivity of the tests.
To check on this hypothesis, we recruited eight asth-
matic children of school age on whom two sets of base-
line FOT recordings were performed 5 min apart,
without spirometry between them. The short-term vari-
ability of each FOT parameter decreased substantially
(Table 1), suggesting that the sensitivity of the FOT test
for the detection of AH can be potentially doubled if
the measurements are performed without additional
lung function tests requiring special breathing maneu-
vers. The short-term variability of Rrs in this subgroup
of children ﬁts well within the range reported in earlier
studies (5–11%), where FOT was performed without
spirometry.3,8 The somewhat greater variabilities in the
reactance parameters also agree with previous
results.1,3,8 The deep inspiration (DI) itself required for
spirometry may also affect the FOT during bronchial
challenges. DI alleviates the airway narrowing by de-
creasing the enhanced bronchial smooth muscle tone
and advancing lung recruitment. However, in asth-
matics, this reduction may not be present32 or DI may
even enhance the airway tone.33 Since our subjects
were classiﬁed as mild intermittent and mild persistent
asthmatics, it can be anticipated that the bronchoprotec-
tive effect of DI predominated. Thus, it is possible that
the His and MCh effects would have been somewhat
greater if the FOT had have performed alone to assess
the lung function changes.
A further important feature of our study protocol is
the lack of randomization of the FOT and spirometric
measurements. While this order minimized the interfer-
ence between the measurement techniques since FOT
does not modify the bronchial tone, this timing may
have biased our ﬁndings if the bronchoconstriction was
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not stable over the measurement period (approximately
3 min after completing each challenge). To exclude the
potential bias due to the diminished effect of His or
MCh with time, we performed measurements on ﬁve
additional children, where the lung function was
assessed by spirometry at 1, 3, and 5 min after MCh
inhalation at a single dose of 4 mg/ml for 2 min. These
results demonstrated that, within the time frame cov-
ered by the spirometry and forced oscillations, no sig-
niﬁcant reduction in the bronchial tone was observed
(FEV1 decreases were stable with values of
70.3  22%, 68.3  24%, 68.4  19% of the pre-MCh
level at 1, 3, and 5 min after MCh inhalation, respec-
tively, P ¼ 0.74). We are, therefore, certain that our
protocol allows an exact comparison of the two techni-
ques, even in the presence of an elevated airway tone.
In conclusion, in asthmatic children subjected to
bronchoprovocation tests with His and MCh, the resis-
tance and reactance parameters determined with the
FOT detected the airway constriction similarly as for
the parameters assessed by standard spirometry. The Z
scores, which take into account the greater variability in
the changes in the FOT parameters when the FOT was
performed concomitantly with spirometry revealed that
the two lung function measurement methods have simi-
lar sensitivities in the assessment of bronchoconstric-
tion. If the FOT was performed alone, the short-term
variability of the resistance parameters decreases
markedly and approaches that observed for the spiro-
metric indices. Since the FOT requires less cooperation
from the patient than in the case of spirometry, use of
the FOT may impose less stress on the children and
may lead to a decrease in the age at which airway nar-
rowing can be detected during bronchoprovocation
tests. This implies that FOT is feasible for the detection
of AH in children and thus its use may contribute to the
diagnosis of asthma in the preschool age range.
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